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ALGINATE HYDROGEL AS A THREE-DIMENSIONAL EXTRACELLULAR
MATRIX FOR IN VITRO MODELS OF DEVELOPMENT
Catherine Sargus-Patino, M.S.
University of Nebraska, 2013
Advisor: Angela K. Pannier
Tissue engineering, involving the use of three-dimensional (3-D) scaffolds for cell
and tissue culture, is a promising technique for establishing in vitro culture models that
mimic in vivo environments. In vitro models present ethical and cost advantages over in
vivo models, and allow for controlled, mechanistic studies on factors that regulate normal
and abnormal tissue development. Alginate, a linear polysaccharide derived from brown
algae, has properties that make it a favorable material as a 3-D extracellular matrix for in
vitro cell and tissue models. After demonstrating alginate’s tunable physical and chemical
properties with respect to gel formation, stiffness, and cellular interactions, alginate
hydrogel was employed in two separate culture systems that share in common the
ultimate goal of serving as in vitro models of tissue development and function: 1) an in
vitro model of pig embryo elongation to develop strategies for improving pregnancy
outcomes, and 2) an in vitro model of growth plate cartilage to discover factors necessary
for inducing native cartilage architecture for tissue engineering applications. In regards to
pig embryo culture, embryos encapsulated within alginate hydrogels exhibited greater
survival and morphological changes than non-encapsulated control embryos, along with
increased expression of steroidogenic transcripts and estrogen production, consistent with

	
  
in vivo elongation. For the growth plate model, alginate hydrogels were used for the
encapsulation of mouse growth plate chondrocytes in vitro to study the effects of soluble
parathyroid hormone (PTH), a signaling factor that regulates growth plate structure and
function in vivo, along with the effects of an arginine-glycine-aspartic acid (RGD)
peptide conjugated to the alginate. PTH and RGD peptide treatment resulted in decreased
collagen X and Indian hedgehog transcript expression in encapsulated chondrocytes,
demonstrating the role of these factors on the regulation of chondrocyte hypertrophy in
vitro. Overall, information gained from utilizing these in vitro models as research tools
can be used to advance the field of developmental biology and enhance tissue
engineering therapies for the treatment of degenerative diseases.
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CHAPTER 1
Thesis Introduction and Background
1.1. Introduction
The tissue engineering approach to cell and tissue culture, involving the use of
three-dimensional (3-D) scaffolds, is a promising technique for establishing in vitro
culture models that mimic in vivo environments. Alginate, a linear polysaccharide
derived from brown algae, has properties that make it a favorable material as a 3-D
extracellular matrix (ECM) for in vitro cell or tissue models. Alginate forms a hydrogel
by ionic-crosslinking in the presence of a divalent cation, allowing for gentle
encapsulation of cells or tissue. In addition, alginate hydrogel can be chemically modified
to promote specific interactions between cells or tissue and the surrounding hydrogel, or
can be left unmodified to solely provide mechanical support for tissue morphogenesis
and/or cellular responses. For this thesis, alginate hydrogel was used to develop two
separate culture systems that share in common the ultimate goal of serving as in vitro
models for tissue development and function. For the first project, alginate hydrogel was
investigated as a 3-D matrix for the in vitro development of pre-implantation pig
embryos. Between day 10 and 12 of gestation in the pig, embryos undergo a dramatic
morphological change, known as elongation. Deficiencies in elongation contribute to
approximately 20% of embryonic loss, but exact mechanisms of elongation are poorly
understood. In order to provide an in vitro tool for evaluating mechanisms of elongation,
the first objective of this thesis was to utilize alginate hydrogels as 3-D scaffolds for the
encapsulation and support of porcine embryo elongation in vitro. Secondly, alginate
hydrogel was investigated as a 3-D matrix for the establishment of an in vitro growth
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plate model. Physical damage or congenital disorders that disrupt growth plate cartilage
result in skeletal abnormalities that are often associated with long-term intensive
healthcare needs due to impact on the joints, central nervous system, and ocular system.
Studying the generation of growth plate architecture in vitro is critical for understanding
mechanisms that regulate normal development of growth plate cartilage and how these
mechanisms are altered in abnormal growth plates, in addition to enhancing tissue
engineering strategies. Therefore, the second objective of this thesis was to determine the
extracellular factors required to induce native growth plate structure and function within
3-D alginate hydrogels. Overall, in addition to advancing the field of developmental
biology, the physiological information gained from using these in vitro models as
research tools can be used to enhance fertility and pregnancy outcomes as well as tissue
engineering and cell-based therapies for the treatment of degenerative diseases.

1.2. Tissue Engineering
	
  
The use of autologous or allogeneic grafts in traditional transplantation surgeries
has serious limitations, including a lack of available donor tissues and severe immune
responses, respectively [1]. Tissue engineering is a relatively new field that combines
engineering with the life sciences in order to develop functional tissue substitutes, and
has the potential to revolutionize medicine by providing optimal replacement tissues for
those damaged due to injury or disease [2]. Advantages of tissue engineering include the
use of autologous or allogeneic cells to overcome the limitation of donor tissue
availability, as well as the ability to directly control in vitro culture conditions to model
those that occur in vivo [3]. The basic principle of tissue engineering involves three main
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components [4]. First, living cells are needed in order to produce the desired tissue. The
cells are often derived from donor tissue or from stem or progenitor cells [2, 4].
Secondly, a 3-D scaffold is needed to provide structural support for the growing tissue
and maintenance of cell-to-cell communication. These scaffolds often mimic the in vivo
environment of the tissue by setting appropriate mechanical properties and chemical
signals. Tissue engineering scaffolds can be made of synthetic materials, such as the
polyglycolic or polylactic family of polymers, or they can be made of natural materials,
such as collagen, alginate, or chitosan [2-5]. The final essential component of tissue
engineering is the inclusion of bioactive signals, as they are used to establish cell-scaffold
interactions and provide the necessary chemical stimuli to promote cell growth and
differentiation [2-4]. Taken together, these three components of tissue engineering can
act synergistically to develop functional tissue substitutes for the replacement of diseased
or damaged tissue.

1.3. Alginate
1.3.1. Structure and properties
Hydrogels, i.e. networks of hydrophilic polymer chains with high water content,
are highly appealing as 3-D scaffolds for in vitro cell and tissue culture due to their
ability to mimic the physical properties of native soft tissue [6], as well as their high
porosity for efficient diffusion of proteins and nutrients [7]. Alginate hydrogel, in
particular, is widely used in tissue engineering applications due to its desirable properties
as a biomaterial [8]. Alginate is a linear polysaccharide produced as an ECM component
in brown algae and some bacteria. The polysaccharide is composed of repeating units of
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β-D-mannuronic acid (M) and α-L-guluronic acid (G) [9] (Fig. 1-1) and forms a hydrogel
by ionic cross-linking of the G residues in the presence of a divalent cation (Fig. 1-2)
[10].
108

K.Y. Lee, D.J. Mooney / Progress in Polymer Science 37 (2012) 106–126

Fig. 1. Chemical structures of G-block, M-block, and alternating block in alginate.
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surface and lower stiffness in the center. In addition, radial channels develop in the gel
when the alginate is crosslinked in CaCl2 solution without the addition of NaCl [12].
Alginate hydrogels can also be formed using internal gelation methods, in which a
calcium slurry, usually calcium carbonate (CaCO3) or calcium sulfate (CaSO4), is mixed
into the alginate solution and gelation occurs as the calcium slowly leaks from within the
alginate [11]. In this case, release of the calcium is caused by a reduction in pH that may
be harmful to cells that are within the alginate solution during gelation. However, the
internal gelation method may be useful for seeding cells on pre-formed alginate scaffolds
[11].
K.Y. Lee, D.J. Mooney / Progress in Polymer Science 37 (2012) 106–126
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Fig. 4. Alginate hydrogels prepared by ionic cross-linking (egg-box model) [38]. Only guluronate blocks participate in the formation of a corrugated
egg-box-like structure with interstices in which calcium ions are placed. Copyright 2007, Elsevier Science Ltd., Oxford, UK.
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3.1.3. Thermal gelation
Thermo-sensitive hydrogels have been widely investigated to date in many drug delivery applications, due to
their adjustable swelling properties in response to temperature changes, leading to on-demand modulation of drug
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In addition to its gentle encapsulation process and diffusion capabilities, alginate
promotes negligible non-specific protein adsorption and cell adhesion, leading to minimal
interaction between encapsulated cells/tissue and the surrounding alginate hydrogel [14].
This feature allows alginate to act as a “blank slate”. If left unmodified, alginate gels can
be used to solely provide mechanical support to cells or tissues; varying the concentration
of alginate alters the mechanical properties of the resulting matrix and can be used to
evaluate the effect of matrix mechanics on cell or tissue growth [15]. Otherwise, specific
extracellular factors can be added to the alginate to control the interaction between
encapsulated cells/tissue and the surrounding alginate hydrogel.
Degradation of alginate hydrogels does not readily occur in physiological
conditions [16, 17], although some de-crosslinking can occur due to the gradual diffusion
of calcium ions out of the matrix [18]. Increased degradation occurs in the presence of a
chelating agent, such as ethylenediaminetetraacetic acid (EDTA), lactate, citrate, or
phosphate, which increases the removal of calcium ions from the matrix [13]. No known
alginate-degrading enzymes exist in humans, but alginate lyases have been isolated from
marine algae and a wide range of microorganisms [11]. Alginate lyases cause degradation
of alginate via a β-elimination mechanism, in which the glycosidic 1  4 O-linkage
between monomers is cleaved [19]. The lack of degradation in physiological conditions
by alginate hydrogels makes alginate an appropriate material for maintaining structural
integrity during relatively long culture times when used for in vitro cell or tissue culture.
Alginate lyase or a chelating agent such as EDTA can then be used to easily retrieve the
cells or tissue from the alginate bead if necessary for further assays. Due to these unique
physical and chemical properties of alginate, along with its innate biocompatibility,
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alginate has been employed in biomedical and food industries, as described below,
including its recent popularity as a matrix for tissue engineering applications.

1.3.2

Applications
Alginate is commonly used in the food industry as a thickening agent to increase

the quality of foods, such as ice cream and dressings, demonstrating its biocompatibility
and low toxicity [11]. It has also been widely used in the pharmaceutical industry as a
drug or protein delivery agent; alginate gels can release macromolecules in a controlled
manner and can be orally administered or injected in a non-invasive approach [20].
Examples of alginate research for pharmaceutical applications include studies on
composite alginate/poly(lactic-co-glycolic) microparticles for insulin delivery [21],
coated chitosan-alginate beads for oral delivery of the antibiotic drug cefaclor [22], and
tamoxifin-loaded nanoparticles for the treatment of breast cancer [23]. Recently, alginate
research has shifted to tissue engineering applications due to its biocompatibility,
relatively low cost, and gentle gelation process [11, 20]. Specifically, alginate hydrogels
are favorable for cell transplantation or immobilization and can be used to deliver cells to
a desired site in vivo or provide a controlled 3-D environment for new tissue formation in
vitro [20]. Alginate gels have previously been used for the encapsulation and culture of a
variety of cell types, including articular chondrocytes [24, 25], skeletal myoblasts [26,
27], neural stem cells [28], and mouse embryonic stem cells [29].
In addition to cell encapsulation, alginate hydrogels have demonstrated success as
a 3-D extracellular matrix for the in vitro culture of organs and embryos, for the purpose
of developmental studies [30], disease simulation [31], and advancing in vitro
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fertilization techniques [32]. In regards to organ culture, alginate hydrogels have
previously been used to support in vitro development of ovarian follicles in mice [15, 32,
33] and nonhuman primates [34], cryopreserved-thawed human cortical follicles [35],
and sections of ovaries and oviducts to model specific changes that might lead to ovarian
cancer [36]. The studies involving mouse ovarian follicle culture have demonstrated that
encapsulation of follicles within alginate hydrogels enhances follicle maturation in vitro
and can lead to subsequent fertilization in vitro [37]. For embryo culture, alginate
hydrogels have previously been successful for the in vitro development of mouse
pronuclear stage embryos [30] and bovine embryos up to the blastocyst stage [38]. The
results of these previous studies provide evidence that alginate has great potential as an
artificial 3-D extracellular matrix that can support in vitro culture of cells, tissues, and
organs, making it the scaffold of interest for the in vitro models established in this thesis.
However, despite the intrinsic properties of alginate that make it a favorable material for
tissue engineering applications, chemical modifications are often required to promote
desirable cellular functions, provide a greater range of mechanical properties, and/or
provide controlled release of encapsulated factors.

1.3.3. Chemical modifications
Alginate’s free hydroxyl and carboxyl groups along its molecule chain provide
numerous sites that are ideal for chemical functionalization. Properties such as
degradability, hydrophobicity, and biological characteristics can be altered by
functionalizing available hydroxyl and/or carboxyl groups, or interfering with carboncarbon bonds [39]. For example, to decrease alginate gel stiffness and increase
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degradability in physiological conditions, oxidation of alginate is often employed, which
lowers the molecular weight (MW) of the polysaccharide [15, 39]. Sodium periodate,
which is used for the oxidation reactions, breaks carbon-carbon bonds of the guluronate
group yielding an adduct that does not form ionic bridges with divalent cations [40];
therefore, less crosslinking occurs, leading to lower mechanical stiffness of the resulting
gel. Furthermore, partial oxidation of alginate creates acetal groups that are susceptible to
hydrolysis. Consequently, increasing the degree of oxidation increases degradability of
the resulting alginate gel in physiological conditions [41].
Another useful chemical modification of alginate is sulfation, prepared through
the reaction of alginate with chlorosulfuric acid in formamide [39]. This process gives
alginate a structural similarity to heparin and therefore promotes high blood
compatibility. Sulfation of alginate also mimics heparin’s high affinity for certain growth
factors; therefore, alginate-sulfate hydrogels have been used to provide protection and
sustained release of heparin-binding growth factors, such as basic fibroblast growth
factor, which is valuable for in vivo delivery systems and tissue engineering applications
[42].
A common modification of alginate, especially for cell encapsulation purposes, is
amidation, in which carbodiimide chemistry is used to form amide linkages between
amine-containing molecules and the carboxylic acid functional groups of the alginate
polymer backbone [39]. This type of chemistry is useful for covalently linking specific
peptides to the alginate backbone to promote cell-matrix interactions, as cell adhesion is
often a strict requirement for cell viability and proliferation [14]. The arginine-glycineaspartic acid (RGD) peptide sequence, which is found in extracellular matrix proteins
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such as fibronectin and laminin, is the most effective and commonly used peptide
sequence to promote cell adhesion [43]. When covalently linked to alginate, RGD peptide
sites serve as ligands to cell integrins to mediate cell migration and adhesion, and the
ligand density can be varied to produce a desired degree of adhesion [14]. Overall, the
tunable physical and chemical characteristics of alginate make it an ideal candidate as a
3-D matrix for tissue engineering strategies, including those used for the establishment of
in vitro models of tissue development and function, as described below.

1.4. In vitro models of development
While traditional tissue engineering studies have focused on using scaffolds for
tissue regeneration for transplantation therapies, as described earlier, the field of tissue
engineering, in particular the use of scaffolds, is now being explored for other
applications, such as studies on drug efficacy and toxicology as well as investigations on
tissue development and morphogenesis. For these applications, an in vitro tissue model
presents ethical and cost advantages over in vivo models, and allows for mechanistic
studies on simple, controlled systems [44]. Traditional two-dimensional (2-D) culture
systems result in a disruption of cell-to-cell interactions as cells attach to the substrate
and migrate away from the tissue [33, 45]. Consequently, cells and tissue often behave
very differently when cultured in two dimensions and experience major differences in
gene expression due to the lack of a natural 3-D environment [46]. Three-dimensional
culture systems can maintain embryo or tissue architecture and allow for direct physical
interaction with the surrounding environment, which better mimics in vivo development.
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Therefore, the tissue engineering approach provides an exciting, more physiologically
natural alternative to traditional 2-D systems as in vitro models of development.
The use of tissue engineering principles to establish in vitro models that closely
resemble in vivo conditions provides a means for researchers to evaluate normal and
abnormal embryo or tissue development, as well as factors that affect development.
Understanding native embryo and tissue development is important for advancing the field
of developmental biology, which focuses on uncovering mechanisms involved in cell
growth, differentiation, and morphogenesis. Knowledge of developmental biology
mechanisms, specifically those involving gene regulation of cell differentiation and tissue
specification, can be integrated with other biological fields to help solve major questions
that still exist in those areas [47].
Examples of in vitro culture systems that have employed the tissue engineering
approach include models for ovarian follicle [32-34] and embryo development [48-51], as
well as in vitro organ models such as kidney [31], cardiac [52], skin [53], and oviduct
models [36]. Human skin models, in particular, have served as in vitro test systems for
pharmaceutical research [53], and cardiac tissue models have provided a means for
electrophysiological studies of the heart [52], a complicated task to evaluate by in vivo
measures. In addition, in vitro tumor models have recently become highly appealing for
studying the efficiency of chemotherapy drugs [54], as well as factors involved in tumor
initiation and progression [55]. The physiological and pathophysiological information
gained from using these in vitro models as research tools can be used for enhancing
fertility and pregnancy outcomes as well as tissue engineering and cell-based therapies
for the treatment of degenerative diseases. The research presented in this thesis
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specifically focuses on the establishment of two separate in vitro models of development
using alginate hydrogel as the 3-D matrix: a model for the development of preimplantation pig embryos and an in vitro growth plate model. The context and impact of
these two culture models are presented in the following sections.

1.5. Pre-implantation pig embryo development
1.5.1. Developmental hallmarks
	
  
In the pig, the pre-implantation period of pregnancy is characterized by several
developmental hallmarks that have significant impacts on embryo survival, uterine
capacity, and subsequent pre-weaning survivability. Between day 10 and 12 of gestation,
the embryo is transformed from a spherical structure (~1-2 mm) to a long thin, filament
(>100 mm) in a process referred to as elongation [56]. During elongation, the embryo
produces and secretes estrogen, which serves as the key molecule for maternal
recognition of pregnancy and also modulates the production and secretion of proteins and
growth factors within the uterus [56]. Elongation of the pig embryo is also characterized
by significant changes in gene regulation as the embryo undergoes this transition [57,
58]. In conjunction with the increase of estrogen production and secretion by the embryo
during elongation, several transcripts involved in steroidogenesis, such as steroidogenic
acute regulatory protein [59], cytochrome P450 side chain cleavage (CYP11A1), and
aromatase (CYP19A1), are increased in a similar pattern as estrogen production during
embryo elongation [58, 60]. Unlike elongation in other domestic animals, rapid
elongation of the pig embryo has been primarily associated with cellular remodeling and
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differentiation rather than cellular hyperplasia [61]. As a result, potential markers for
differentiation of the trophectoderm (i.e., cytokeratin-18 [KRT18]) and mesoderm (i.e.,
vimentin [VIM]) have been identified in the elongating pig blastocyst [62-64].
Proper interactions between the embryo and receptive uterine endometrium are
essential for supporting embryonic development and subsequent implantation [65]. These
interactions are initiated by the immune responsive cytokine, interleukin-1β (IL1B),
which is produced by the embryo and uterine endometrium during elongation and may be
responsible for suppressing the maternal immune response to prevent rejection of the
embryo [66]. The increase in IL1B expression during trophoblastic elongation, and its
association with the initiation of estrogen production by the embryo, suggests that IL1B
may have a critical role in pre-implantation embryo development [67].
Many uterine specific factors have been shown to be up-regulated within the
uterine milieu as the embryo initiates elongation and subsequently transitions to its
superficial implantation on the uterine endometrium [68]. For instance, fibroblast growth
factor 7 (FGF7), transforming growth factor-betas (TGFBs), osteopontin (OPN),
fibronectin (FN), and laminin (LN) have been suggested to play a role in embryomaternal interactions during elongation and implantation [69, 70]. OPN, in particular, is
an ECM glycoprotein secreted by uterine epithelial cells that plays a role in the porcine
implantation cascade during pregnancy [71]. Previous evidence has suggested that the
RGD peptide of OPN binds to integrins alpha 5 and beta 3 on the embryonic
trophectoderm, inducing cytoplasmic reorganization during embryo elongation by
stimulating cell-cell adhesion and promoting cell migration [71]. OPN has been shown to
enhance development of early porcine embryos to the blastocyst stage in vitro when
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added exogenously to culture media [72]. The surface of the oviduct and uterus contains
several other ECM components that have been found to influence embryonic
development, morphogenesis, and function by stimulating cell-cell interactions [73, 74].
Two ECM glycoproteins involved in cellular adhesion, FN and LN, have previously been
shown to increase the hatching rates of cultured human embryos when added to the
culture media [75]. A study involving the culture of porcine blastomeres on FN-coated
culture dishes demonstrated that FN enhanced development to the blastocyst stage
compared to control treatment groups [76], suggesting its role in early embryonic
development. Given the potential involvement of these growth factors and ECM
components during early embryonic development in the pig, further investigations are
warranted to elicit the exact mechanisms of pig embryo elongation. The alginate culture
model established in this thesis for pre-implantation pig embryo development can serve
as the necessary tool for studying the affects of these factors on embryo development and
elongation in a controlled, in vitro environment. In addition to advancing knowledge in
reproductive biology, the mechanisms uncovered with our in vitro culture model can be
used to address critical issues with embryonic loss, as described below.

1.5.2. Embryonic loss in the pig
In the pig, 30-50% of ova released from the ovary do not result in a piglet, despite
a typically high fertilization rate (>95%) [77, 78]. Therefore, low pregnancy rates are
primarily the result of early embryonic or fetal loss. Approximately 20 percent of
embryonic loss occurs during the pre-implantation period of pregnancy in the pig, with a
significant proportion of these losses occurring due to deficiencies in embryo elongation
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[77]. Furthermore, adequate embryo elongation is necessary for successful implantation
and ultimately affects embryo spacing, placental development, and fetal growth, which
have implications on uterine capacity, litter size, and even postnatal piglet health [79].
Better understanding of factors that regulate elongation is needed in order to assess
mechanisms contributing to embryonic loss. Knowledge of these mechanisms can then be
used to develop strategies (e.g. marker-assisted selection, nutrient or hormone
supplements that may improve reproductive efficiencies by decreasing embryo losses in
early gestation) to improve pregnancy outcomes in the pig and potentially other domestic
agricultural species. Therefore, an in vitro model that can facilitate embryo elongation is
essential for evaluating factors that promote or impede elongation. However, past efforts
to establish such models have not been met with success.

1.5.3. Previous studies on in vitro elongation of embryos
Previous attempts to culture embryos at later stages, incorporating a type of
supporting structure, have been largely unsuccessful. In cattle, limited elongation of
embryos in vitro was demonstrated using an agar gel tube system [48, 49, 80]; however,
embryos cultured in this system had deficiencies in the development of the embryonic
disk [49, 81]. This agar system did not provide for complete encapsulation and support of
the embryos. Instead, the tubes merely served as reservoirs for growth, and the embryos
grew to fill these tubes via physical induction. Thus, the shape of the tube may have
forced growth that appeared as elongation, and the high percentages of agar used may
have restricted optimal embryonic development. Furthermore, high levels of media
supplements may have resulted in rapid cell growth, further contributing to the
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appearance of embryonic elongation. Nevertheless, attempts to replicate these results
using pig embryos have been unsuccessful [81].
Moreover, a previous study that investigated morphological changes of in vivoproduced bovine embryos within the agar gel tube system reported that only 3% of the in
vivo-produced embryos initiated morphological changes following in vitro culture [82].
These findings highlight the dramatic environmental change that in vivo-produced
embryos experience when transitioning from the uterine environment to an in vitro
environment. Therefore, more efficient in vitro embryo culture systems are needed that
can ease the embryo’s transition from the uterine environment and facilitate
morphological changes that are consistent with in vivo elongation. The in vitro alginate
culture system developed for this thesis (described in Chapter 3) addresses this critical
need by serving as a model that can facilitate embryo morphological changes and other
corresponding hallmarks of elongation. This alginate culture system was then translated
to serve as an in vitro matrix for the establishment of a growth plate model in the second
part of this thesis, the context of which is described in the following sections.

1.6. Architecture and development of growth plate cartilage
1.6.1. Zonal arrangement of chondrocytes
Longitudinal growth of long bones occurs at the ends of the epiphyseal plate, also
known as the growth plate, which is a distinct cartilage region located at each end of a
long bone [83]. The complex development of the growth plate, involving an array of
signaling pathways for controlled patterning and growth of long bones, can serve as a
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template for natural tissue regeneration, which has become a major focus of tissue
engineering studies [84]. Within growth plate cartilage, chondrocytes differentiate in a
spatially regulated manner that results in morphologically and functionally distinct zones
of cells, forming a continuum from the long bone’s epiphysis towards the diaphysis (Fig.
1-3) [83, 85]. At the epiphyseal end, small, round progenitor cells make up the resting
zone. These relatively quiescent cells enter into the cell cycle and begin to differentiate
into rapidly proliferating, flattened chondrocytes that organize into columns as they
divide, making up the proliferative zone of about 10-20 cells per column [83, 84]. The
chondrocytes of the resting and proliferating zones secrete structural proteins,
predominately type II collagen, forming a hyaline cartilage matrix [83, 85]. Continuing
towards the diaphysis, the chondrocytes stop dividing and begin to differentiate further
into prehypertrophic cells, adopting a more spherical morphology [84]. The
prehypertrophic chondrocytes terminally differentiate into hypertrophic chondrocytes that
swell, i.e. hypertrophy, increasing their volume about 5-10 fold during the process [84].
This increase in size is a principal contributor of longitudinal bone growth and therefore
bone lengthening is primarily driven by the production of hypertrophic chondrocytes
from the proliferating columns [83, 84]. Chondrocytes in the hypertrophic zone primarily
synthesize type X collagen and remodel the cartilage matrix into a calcifying matrix [84,
85]. At terminal differentiation, chondrocytes induce blood vessel invasion through the
secretion of specific proteins such as vascular endothelial growth factor (VEGF) and
attract bone-forming osteoblasts [83, 85]. Finally, hypertrophic chondrocytes undergo
apoptotic cell death and osteoblasts invade the mineralized cartilage matrix, leading to
the initiation of bone formation [83, 85]. One distinction between engineered and native
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cartilage is that engineered cartilage lacks the proper zonal arrangement of cells and
extracellular matrix despite having normal gene expression profiles, suggesting that
certain factors for inducing normal tissue architecture are yet to be determined. Several
signaling pathways, which are described below, have been discovered to play a role in
regulating growth plate architecture and function; however an in vitro growth plate model
is warranted in order to determine additional factors that are required to induce normal
growth plate structure and function.

Fig. 1-3. Functional zonal arrangement of the growth plate within long bones.

1.6.2. Signaling pathways and transcription factors that regulate growth plate function
The orderly progression of cell proliferation and differentiation in growth plate
cartilage is regulated by a complex network of opposing signaling pathways.
Chondrocyte proliferation in the growth plate is partly regulated by a feedback loop
involving the interactions of Indian hedgehog (Ihh), a member of the hedgehog family of
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secreted ligands, and parathyroid hormone-related protein (PTHrP) [83-85] (Fig. 1-4).
Prehypertrophic chondrocytes exiting the proliferative columns express Ihh, which
stimulates the production of PTHrP by resting cells and perichondral cells, i.e.
chondrocytes located at the bone ends near the articular surface [83, 85]. Ihh diffusion to
the perichondral cells is regulated by heparin sulfate proteoglycans (HSPGs) in the
extracellular matrix [86]. The PTHrP binds to its parathyroid hormone/PTHrP receptor
expressed by proliferating chondrocytes and suppresses chondrocyte hypertrophy,
retaining the chondrocytes in the proliferative zone [83, 85]. As chondrocytes in the
proliferative columns become too distant from the PTHrP-producing cells located at the
bone ends, PTHrP concentration becomes too low to stimulate them; this lack of
stimulation causes the chondrocytes to stop proliferating, enter the pre-hypertrophic
phase, and begin to synthesize Ihh [84]. This feedback loop therefore regulates the length
of the proliferative columns in growth plate cartilage, defining individual zones of
chondrocyte maturation.

Fig. 1-4. Schematic illustration of the Ihh/PTHrP feedback loop.
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Other signaling pathways that regulate endochondral development of bones
include bone morphogenic proteins (BMPs), transforming growth factors, Wnts, and
Fibroblast growth factors. These pathways, in addition to the Ihh-PTHrP signal pathway,
influence growth plate function partially via the regulation of key transcription factors,
most notably Sox9 and Runx2 [83, 85]. Sox9 acts at every stage of chondrocyte
differentiation in the growth plate. It is expressed in mesenchymal cell condensations and
is essential for converting them into chondrocytes [83, 84]. Sox9 is also expressed in
proliferating chondrocytes but not in hypertrophic chondrocytes, and is necessary for
restricting chondrocyte differentiation, preventing cells from converting to hypertrophic
chondrocytes prematurely [83]. Furthermore, Sox9 is critical for stimulating the
expression of many ECM components, including Collagens type II, IX, XI and aggrecan
[84, 87]. Runx2, on the other hand, is necessary for driving proliferative chondrocytes to
differentiate further into hypertrophic chondrocytes [83]. In addition, Runx2 promotes the
differentiation of mesenchymal progenitor cells into osteoblasts [84]. It is expressed in all
osteoblasts as well as in hypertrophic chondrocytes [84].
Although significant advances have been made in discovering signal pathways
and signaling gradients that regulate growth plate function, it is unclear whether these
factors alone are sufficient to induce normal growth plate structure and function because
current methods for in vitro culture of naïve chondrocytes do not generate native cartilage
architecture. An in vitro model of the growth plate can therefore serve as the necessary
tool for evaluating these factors. Defining the microenvironmental parameters that
generate cartilage architecture is a crucial step toward the development of systems to
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regenerate native cartilage, with the ultimate goal of addressing critical health issues that
are described in the following section.

1.6.3. Cartilage injury and disease
Physical damage or genetic disorders that disrupt normal growth plate function
can result in skeletal abnormalities. Osteochondrodysplasias, a group of disorders
characterized by abnormal growth and remodeling of bone and cartilage, affect between
1/3000 to 1/5000 individuals and occur with over 200 different phenotypes [88].
Mutations responsible for these dysplasias may cause defects in the synthesis of
extracellular matrix proteins, specific growth factors, receptors, and transcription factors
[89]. These dysplasias often result in disorders of decreased or increased bone density
leading to proportionate short stature in the case of osteodysplasias, or disproportionate
short stature with short trunk or short limbs in the case of chondrodysplasias [88]. In
addition to affecting quality of life, short stature and craniofacial defects are often
associated with long-term intensive health care needs as a result of impact on the joints,
the central nervous system, and the ocular system [90, 91]. Therefore, along with
advancing the field of developmental biology, studying the generation of growth plate
architecture in vitro is critical for enhancing tissue engineering strategies to provide
optimal replacement tissue for abnormal or damaged growth plates. While an in vitro
growth plate model has the potential to serve as a tool for these studies, proper zonal
arrangement of chondrocytes, in particular the proliferating columnar zone, has not yet
been established by previous efforts, which are described in detail below.
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1.6.4. Previous studies on engineering growth plate cartilage
Previous attempts to establish an in vitro growth plate model have failed to induce
native growth plate architecture, in particular a distinct zone of proliferating columnar
chondrocytes. A study involving the encapsulation of porcine growth plate chondrocytes
in 1.25% alginate beads demonstrated that expression patterns of hormone receptors and
matrix proteins in chondrocytes cultured in alginate beads were more similar to that of
native growth plates than chondrocytes grown in 2-D monolayers [92]; however, there
was no report of proliferating chondrocytes forming columns within the alginate gels.
Another study involving the encapsulation of proliferating chondrocytes from fetal
bovine chondrocytes demonstrated that a 102-mM calcium chloride (CaCl2) cross-linking
solution, without the addition of sodium chloride, caused radial channels to form within
the alginate beads, and that proliferating chondrocytes became aligned within these
channels [12]. Although this alignment appeared to mimic the columnar arrangement of
proliferating chondrocytes in vivo, no further characterization of the chondrocytes other
than electron microscopy was performed. The chondrocytes may have simply been filling
these channels due to physical restriction; no evidence was reported of the encapsulated
chondrocytes maintaining the appropriate genotype of native proliferating chondrocytes
of the growth plate. More recently, a study was conducted to differentiate human bone
marrow-derived mesenchymal stem cells (hBMSCs) within layered agarose constructs in
order to promote zonal arrangement of chondrocytes [93]. Zonal cartilage did develop to
an extent in this study due to the mechanical gradient of the scaffold, with small collagen
type II negative proliferative cells at the base of the constructs and hypertrophic
chondrocytes towards the surface. However, although proliferation was detected, a
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distinct zone of proliferating columnar chondrocytes was not observed [93]. Therefore, a
need still exists to establish a 3-D in vitro growth plate model that exhibits normal growth
plate structure and function in order to elucidate mechanisms that regulate formation of
proliferative chondrocyte columns, which in turn can be used to enhance tissue
engineering strategies. The alginate hydrogel system established for this thesis involving
the 3-D encapsulation of growth plate chondrocytes has the potential to address this need.

1.7. Objectives of thesis
The overall objectives of this thesis are to employ alginate hydrogels as a 3-D
matrix to establish in vitro models of development and then evaluate factors that regulate
growth and development in these systems. Specifically, this thesis focuses on two
developmental models: 1) an in vitro culture system that can support porcine embryo
elongation, and 2) an in vitro model of growth plate cartilage. These in vitro models can
be used as tools for studying mechanisms of development and identifying factors that
regulate or enhance tissue growth and function. Chapter 2 will detail hydrogel design and
characterization that was explored for these projects. Chapter 3 will describe studies
focused on porcine embryo development within alginate gels and Chapter 4 will focus on
the preliminary studies involving the growth plate model. Finally, Chapter 5 will
conclude the findings of this thesis and describe plans for future investigations.
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CHAPTER 2
Alginate gel design and characterization
2.1. Introduction
As described in Chapter 1, the fundamental elements of tissue engineering include
cells, bioactive signals, and a 3-D scaffold to simulate the natural cellular environment by
maintaining cell/tissue architecture and providing stimuli for growth and differentiation
[4, 5]. The in vitro culture models established in this research project predominantly
capitalize on the scaffold element of the tissue engineering approach to cell and tissue
culture. Scaffold design is dependent on several factors, including physical properties
(e.g. shape and mechanical integrity), mass transport properties (e.g. protein diffusion
rate), and biological properties (e.g. cell adhesiveness), which greatly affect the success
of tissue organization and development [1, 5]. Biomaterials that can be easily tuned to
address these properties are ideal for tissue engineering applications so that optimal
properties can be obtained for the desired outcomes. Hydrogels, i.e. networks of
hydrophilic polymer chains with high water content, are a class of biomaterials that are
widely used as tissue engineering scaffolds due to their ability to mimic the properties of
native soft tissue [6], as well as their high porosity for efficient diffusion of proteins and
nutrients [7]. Synthetic hydrogels such as polyethylene glycol [94] and natural hydrogels
such as chitosan [95] and alginate [14] can be modified both physically and/or chemically
to promote mechanical and biological cues, making them favorable as scaffolds for in
vitro cell and tissue growth. This chapter will specifically focus on the design and
characterization of alginate hydrogels as scaffolds for tissue engineering applications, in
particular for use as in vitro culture models.
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The principal purpose of a tissue engineering scaffold is to provide a framework
in which tissue growth can occur by filling a space otherwise occupied by a native tissue
or environment [5]. Physical properties that are essential to the success of the scaffold
include gel formation characteristics and mechanical properties. As gel formation can
dictate the direction in which tissue growth proceeds and how cell/tissue architecture is
maintained, the first objective of this study was to investigate several methods for
creating alginate gels of different forms, specifically focusing on designs that involve the
external method of gelation (i.e. the use of calcium chloride [CaCl2] as the crosslinking
agent). Mechanical properties of the gel should also be considered when exploring the
optimal scaffold design for a specific application. The alginate gel must have enough
structural integrity to withstand manipulation and maintain 3-D architecture of the
encapsulated tissue for adequate cell-to-cell communication [5]; however, the gel must
also be lenient enough to guide, not inhibit, cell and tissue growth. In addition, when cell
integrins are coupled to the ECM, mechanical forces can be transduced into biochemical
signals that influence cell behavior and function within the scaffold, a phenomenon
known as mechanotransduction [96, 97]. Therefore, the stiffness of the artificial in vitro
ECM (i.e., the scaffold) with which the cells are in contact can be an important regulator
of basic cellular processes of proliferation, differentiation, and remodeling [96]. Stiffness
was evaluated in the present study by determining Young’s modulus as a function of
alginate concentration.
In addition to physical properties, bioactivity is another design variable to
consider when establishing a tissue engineering scaffold, as the scaffold must promote
desired cellular functions and therefore proper tissue development [1, 5]. For example,
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biomaterials can be modified to present specific ligands for cell adhesion, which can
influence cell-matrix interactions and can lead to altered gene expression and cellular
behavior [1]. Due to their very hydrophilic nature, many hydrogels, including alginate, do
not readily promote protein adsorption or cell adhesion unless chemically modified [5,
14]. The amino acid sequence arginine-glycine-aspartic acid (RGD), derived from
numerous ECM proteins such as fibronectin, laminin, and collagen, is the most effective
and commonly used peptide sequence for hydrogel modification to promote cell adhesion
[5, 43]. Therefore, covalent attachment of an RGD peptide to the alginate polymer
backbone and subsequent characterization of the conjugation were investigated in this
study.
Overall, the objective of these studies was to demonstrate alginate’s ability to be
modified with respect to physical properties (i.e., gel formation and stiffness) as well as
bioactivity (i.e. cell adhesiveness). Each of these gel design variables can then be used to
investigate its influence on porcine embryo development and growth plate development
with the in vitro culture models established and described later in this thesis.

2.2. Methods
2.2.1. Gel formation
This section details several methods that were developed for creating alginate gels
of different morphologies. The crosslinking solution used for each of these methods was
prepared by dissolving calcium chloride (CaCl2; Sigma Aldrich, St. Louis, MO) and
sodium chloride (NaCl; Sigma Aldrich) in sterile MilliQ water to obtain a 50 mM
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CaCl2/140 mM NaCl solution. Alginate solutions were prepared by dissolving
lyophilized alginate powder (Pronova UP MVG, >60% guluronic acid, 200,000 –
300,000 g/mol; NovaMatrix, Sandvika, Norway) in sterile MilliQ water. The gel
formation methods described below were tested with alginate concentrations ranging
from 0.375% to 1.5% alginate (w/v).

Alginate beads:
A simple “drop” method, based on methods described by other investigators [33,
98], was developed through our studies for the encapsulation of cells and tissues within
alginate hydrogel beads (Fig. 2-1A) [50]. To create alginate beads on a scale large
enough for the in vitro pig embryo model described in Chapter 3, 25-µL drops of alginate
solution were slowly released from the edge of a wide-orifice pipette tip and gently
touched to the surface of crosslinking solution (50 mM CaCl2/140 mM NaCl) to pull the
droplet off the tip and into the solution. After 3 minutes of crosslinking time to ensure
complete gelation, the beads were removed from the crosslinking solution and diameters
were measured using a caliper. For cell encapsulation, this method was modified to
produce smaller beads using 10-µL drops of alginate for the in vitro growth plate model
investigated in this project. The “drop” method was then extended to allow for the
addition of multiple layers of alginate gel around the first bead to ensure complete
encapsulation of pig embryos, which was utilized in the studies described in Chapter 3
(Fig. 2-1B). This double encapsulation method was also developed for future
mechanical/chemical gradient or co-culture studies. To demonstrate the addition of a
second layer, the 25-µL beads prepared during the first encapsulation were placed
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individually into 45-µL drops of alginate. These drops containing the beads were then
pipetted into crosslinking solution (50 mM CaCl2/140 mM NaCl) using a wide-orifice
pipet tip, and were allowed to gel for an additional 3 minutes, resulting in double-layered
alginate beads. The double-layered bead was observed with a Leica DMI 3000B inverted
microscope (Leica Microsystems GmbH, Wetzlar, Germany) at 5x magnification.	
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Fig. 2-1. Schematic illustration of the formation of alginate hydrogel beads, in conjunction
with the encapsulation of embryos. A) Single encapsulation, resulting in an embryo
encapsulated within one layer of alginate hydrogel. B) Double encapsulation, resulting in an
embryo encapsulated within two layers of alginate hydrogel.

Cylindrical alginate gels:
An alginate hydrogel with a cylindrical morphology could provide extended space
for tissue growth, while still maintaining a small enough radius for adequate diffusion of
nutrients to the cells or tissue located within the gel. To create cylindrical alginate
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hydrogels, a custom mesh mold was developed, consisting of a polypropylene mesh piece
(0.021” x 0.027” opening size; McMaster Carr, Elmhurst, IL) held together with stainless
steel syringe connectors (McMaster Carr) on each end (Fig. 2-2A). Approximately 500
µL of alginate solution was pipetted directly into the cylindrical mold via the opened slit
at the top of the mesh. The mold was then lowered into crosslinking solution (50 mM
CaCl2/140mM NaCl) for 10 minutes to allow for complete gelation. After 10 minutes, the
mold was removed from the crosslinking solution, the syringe connectors were taken off
the ends of the mesh, and the resulting gel was gently peeled from the mesh using
forceps. The diameter of the resulting gel was measured with a caliper. To create a
cylindrical hydrogel for gradient and/or co-culture studies, alginate solutions of various
concentrations (0.375% to 1.5%; dyed with food coloring) were consecutively added to
the mesh mold (Fig. 2-2B) to demonstrate the formation of a mechanical gradient gel.

Fig. 2-2. A) Mesh mold used for creating cylindrical gels. B) Example of a gradient gel precrosslinking; each dye color represents a different concentration of alginate solution.

Alginate gel tubes:
A different approach to maintaining tissue architecture is to provide a reservoir
for growth, in contrast to directly encapsulating the tissue within the hydrogel. Therefore,
a method for creating a tubular alginate hydrogel was investigated and developed for this
approach. Briefly, a glass microdispenser tube (Drummond, Broomall, PA) with a 1.5-
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mm outer diameter was added through the center of the mesh mold that was described
above for creating cylindrical gels (Fig. 2-3). Alginate solution was then pipetted into the
mesh mold, filling the space around the glass tube. After placing this mesh system into
crosslinking solution for 10 minutes, the metal syringe connectors were removed from
the ends of the mesh and the glass tube was slowly drawn out from the center of the gel.
Finally, the resulting gel was carefully peeled from the mesh using forceps.

Fig. 2-3. Mold for creating alginate gel tubes, consisting of
a cylindrical mesh frame with glass tube through the
center.

Alginate wells:
In addition to the hollow gel tube method described above, another method of
creating a reservoir for tissue growth was developed, involving the creation of wells
within alginate hydrogels. To create the wells, a long, narrow mesh mold was
constructed, with an opened top in which to pipette the alginate solution. Alginate
solution was then pipetted into the mesh mold until full, followed by the insertion of a gel
electrophoresis comb into the alginate solution. This system was then placed into a basin
of crosslinking solution (50 mM CaCl2/140 mM NaCl) (Fig. 2-4) for 1 hour to ensure
stability of the resulting gel. After being removed from the crosslinking solution, the
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comb was carefully removed from the alginate, and the resulting gel was peeled from the
mesh mold.

Fig. 2-4. The setup for the formation of alginate wells. A) Mesh system containing
alginate, with gel electrophoresis comb inserted. B) Close-up of comb inserted into
mesh mold.

2.2.2. Chemical modification of alginate
The RGD amino acid sequence is the most effective and commonly used peptide
sequence for hydrogel modification to promote cell adhesion [5, 43]. To create bioactive
alginate hydrogels, alginate was covalently modified with a glycine-arginine-glycineaspartic acid-serine-proline (GRGDSP) peptide (Anaspec, Fremont, CA) to a
concentration of 4 µmol/g alginate using carbodiimide chemistry, as previously described
[14]. Briefly, two grams of sodium alginate (NovaMatrix) were added to 200 mL of MES
buffer (0.1M MES, 0.3M NaCl, pH 6.5) and the alginate was allowed to dissolve for 7-8
hours on a stir plate. 1-ethyl-(dimethylaminopropyl) carbodiimide (EDC; Sigma Aldrich)
was added to activate 5% of the uronic acids of the alginate polymer backbone in order to
form amide linkages with the peptide. To stabilize the reactive EDC intermediate against
a competing hydrolysis reaction, N-hydroxy-sulfosuccinimide (sulfo-NHS; Pierce,
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Rockford, IL) was also added to the solution at a 2:1 EDC to NHS ratio. Lastly, the
GRGDSP peptide was incorporated into the solution, conjugating to the alginate
backbone via the terminal amine of the peptide. After 20 hours of reacting, the
conjugation reaction was quenched through the addition of hydroxylamine hydrochloride
(Sigma Aldrich). The alginate solution was then dialyzed against decreasing salt solutions
and finally ddH2O over the course of 3 days. The final dialyzed solution was lyophilized
to dryness and stored at -80°C until use.

2.2.3. Confirmation of peptide conjugation
Because unmodified alginate does not readily promote cell adhesion, a cell
adhesion experiment was performed with unmodified alginate gels compared to
GRGDSP-conjugated alginate (RGD-alginate) gels as an indirect method of confirming
successful conjugation of the peptide. Briefly, 200 µL of 1% alginate or RGD-alginate
solution was pipetted into wells of a 48-well plate. Next, 20 µL of 100 mM calcium
chloride (CaCl2) solution was pipetted into the center of each well of alginate or RGDalginate solution. After 20 minutes of crosslinking, the gels were removed from each well
and placed into a corresponding well of rinse media (Dulbecco’s Modified Eagle’s
Medium [DMEM]; Gibco/Invitrogen, Carlsbad, CA) to remove excess calcium. After the
rinse step, each gel was transferred to the bottom of a well of a 96-well plate immediately
prior to cell seeding.
Mouse bone marrow mesenchymal stem cells (D1 ORL UVA; ATCC, Manassas,
VA) were cultured in T-75 flasks in DMEM supplemented with 10% fetal bovine serum
(Invitrogen) and 1% penicillin/streptomycin (Invitrogen). For seeding, cells were counted
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using a hemocytometer and trypan blue staining for viable cells after being dissociated
with 0.05% trypsin-EDTA. Cells were then seeded onto each gel (n=3 gels per alginate
condition) at a density of 20,000 cells/cm2 in 150 uL of cell culture media and cultured
for 3 days at 37 ºC and 5% CO2. Gels were imaged 24 and 72 hours post-seeding to
observe cellular adhesion using a Leica DMI 3000B inverted microscope (Leica
Microsystems). Three images were taken per gel at 10x magnification and representative
images are reported. Cells were then stained at 72 hours with 2 µM calcein AM/4 µM
ethidium homodimer-1 and imaged with fluorescence microscopy to evaluate live and
dead cells, respectively.
To further verify successful conjugation of the GRGDSP peptide to the alginate
polymer backbone, NMR spectroscopy was used to characterize the samples. Unmodified
alginate and GRGDSP-alginate were dissolved in deuterium oxide (D2O; Sigma Aldrich)
and placed in separate NMR tubes. The 1H-NMR spectra of the samples were recorded
on a Bruker DRX-500 500 MHz NMR spectrometer at an operating frequency of 500.13
MHz.

2.2.4. Determination of Young’s modulus
Sodium alginate (NovaMatrix) was dissolved in sterile MilliQ water to final
concentrations of 0.375%, 0.5%, 0.7%, 1.0%, and 1.5% (w/v). For each concentration,
alginate solution was pipetted into cylindrical mesh molds (3.5 mm diameter), as
described above in section 2.2.1 for cylindrical alginate gels, and the molds were placed
into crosslinking solution (50 mM calcium chloride/140 mM NaCl) for 10 minutes to
allow for complete gelation of the alginate. Following removal from the mesh molds, the
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gels were cut into 5-mm pieces for mechanical testing. Exact height and diameter of the
cylindrical gels were measured with a caliper and recorded for use in analysis. Young’s
modulus values of the alginate gels were determined using a TMS-Pro texture analyzer
(Food Technology Corporation, Sterling, VA). Samples were compressed 1 mm at a rate
of 1 mm/min while force and displacement were recorded over time. Average Young’s
modulus values were determined from the linear regions of the stress-strain curves, at
strain values ≥ 0.1. These methods were then repeated with 0.5%, 1.0%, and 1.5% RGDalginate gels to any determine any effects of peptide conjugation on Young’s modulus of
the resulting gels.

2.2.5. Statistical Analysis
All values are reported as mean ± standard error of the mean (SEM). For Young’s
modulus studies, one-way analysis of variance (ANOVA) was used to determine if the
mean Young’s modulus values between the different alginate concentrations were
statistically different. Tukey’s multiple comparison test was then used to perform
pairwise comparisons. Student’s t-test was used to compare the Young’s moduli of the
alginate gels with those of the RGD-alginate gels to determine any significant differences
between the two groups. Linear regression analyses were used to describe the relationship
between alginate concentration and Young’s modulus. For these analyses, the r2 value
(coefficient of determination) is reported, giving a measure of the reliability of the linear
relationship.
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2.3. Results
2.3.1. Gel morphologies
A method involving 25-µL alginate drops was developed to produce gels of an
appropriate size for the in vitro pig embryo model. The 25-µL drops resulted in beads of
approximately 3 mm in diameter, which is suitable for 0.5-1.0 mm embryos or tissue
samples (Fig. 2-5A). For cell encapsulation for the growth plate model, the method was
adjusted to make smaller beads, using 10-µL alginate drops. The 10-µL drops resulted in
beads with a diameter of approximately 2.5 mm (Fig. 2-5A). A method for adding
multiple gel layers was then investigated for pig embryo studies, as well as future studies
involving gradients and co-cultures. Encapsulating the first bead within a second drop of
alginate resulted in a double-layered alginate gel, with a second layer gel thickness
ranging from ~200-400-µm around the first bead (Fig. 2-5B).
25-uL

10-uL

2
1

Fig. 2-5. Representative images of alginate beads. A) Alginate beads made from a 25-µL
alginate drop (left) and 10-µL alginate drop (right), B) Representative 5x bright field image of
a double-layered alginate bead: ‘1’ denotes the inner bead and ‘2’ denotes the second alginate
layer (scale bar = 200 µm).

The method developed for creating cylindrical alginate hydrogels, employing a
custom mesh mold, resulted in 3-cm long gel with a diameter of approximately 3.5 mm
(Fig. 2-6A). However, the length of the gel can easily be varied with this mold by
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utilizing mesh pieces of a greater length. This method was then employed to produce a
cylindrical gel with a mechanical gradient. The consecutive addition of alginate solutions
of varying concentrations into the mesh mold resulted in a unified gel post-crosslinking
(Fig. 2-6B). The mesh mold was then modified to produce a hollow tubular gel by adding
a glass capillary tube through the center of the mold, prior to the addition of alginate. The
result was an alginate gel tube with an inner and outer diameter of approximately 1.5 mm
and 5 mm, respectively (Fig. 2-6C and D). 	
  	
  

Fig. 2-6. A) Cylindrical alginate hydrogel, B) Gradient gel consisting of different
concentrations of alginate, dyed with different colors, C) Alginate gel tube prior to
removing glass tube, D) Resulting alginate gel tube.

	
  
The last gel method that was developed and described in the present study was for
the creation of wells within alginate. Using a thin mesh mold and a gel electrophoresis
comb, the result was a long, thin alginate gel consisting of a row of hollow wells (Fig. 2-
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7). These gels in particular consisted of wells with dimensions of 1 mm x 5 mm, with a
gel thickness of approximately 2 mm in between each well.

Fig. 2-7. Representative image of alginate wells, with
dimensions of 1 mm x 5 mm.

	
  
2.3.2. Confirmation of peptide conjugation
Cell adhesion studies were used as an indirect method of confirming successful
conjugation of the RGD peptide to the alginate. D1 ORL UVA cells seeded onto RGDalginate hydrogels demonstrated cell adhesion at the 24-hr time point, while little to no
cell adhesion was observed on the unmodified alginate gels (Fig. 2-8A and B). Cell
number on the RGD-alginate gels appeared to be greater at 72 hours compared to 24
hours, as cells began to form aggregated clusters (Fig. 2-8D). Live/dead staining
confirmed viability of these cell clusters (Fig. 2-8F). In contrast, adhered cells remained
nearly undetected on the unmodified alginate gels at 72 hours post-seeding (Fig. 2-8C
and E). These results therefore confirmed successful peptide conjugation to the alginate
polymer backbone.
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Unmodified Alginate

RGD-Alginate

24 hr

72 hr

72 hr
Live/Dead

Fig. 2-8. Representative bright field images of D1 ORL UVA cells adhered to
unmodified alginate hydrogel gels (A and C), and RGD-alginate gels (B and D), 24 hr
and 72 hr post-seeding. Live/dead staining and subsequent fluorescence microscopy
was performed to confirm cell viability (E and F). Magnification = 10x.
1

H NMR results further confirmed conjugation of the peptide to the alginate

polymer backbone. Figure 2-5 presents the 1H NMR spectra of unmodified alginate (red
spectrum) and GRGDSP-conjugated alginate (blue spectrum). New peaks between δ4 and
δ5 were distinctly detected in the spectrum of the RGD-alginate compared to that of the
unmodified alginate, which can be attributed to the α-hydrogens of the amino acids of the
peptide (Fig. 2-9). Based on previous 1H NMR studies involving this peptide, these peaks
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have been labeled according to the amino acid to which they are most likely attributed
(Fig. 2-9) [99, 100]. Additional peaks that were specifically detected in the GRDSPalginate spectrum compared to the unmodified alginate spectrum between δ1.8 and δ2.8
may be derived from β-hydrogens of the peptide (Fig. 2-9).

§ Alginate
§ GRGDSP-alginate
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Fig. 2-9. 1H-NMR spectra of unmodified alginate (red) and GRGDSP-alginate
(blue) in D2O.

2.3.3. Young’s modulus values
Young’s moduli of alginate and RGD-alginate gels were determined from the
slopes of the linear regions of the stress-strain curves that were plotted after compression
testing. A representative stress-strain curve is depicted in Fig. 2-10. The results of the
compression testing indicated average Young’s modulus values of 2.59 ± 0.20, 3.00 ±
0.15, 7.64 ± 0.51, 7.75 ± 0.46, and 17.3 ± 0.85 KPa for 0.375%, 0.5%, 0.7%, 1.0%, and
1.5% unmodified alginate, respectively (n=20 per concentration; Table 2-1). No
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significant difference was observed between the Young’s modulus values of the 0.375%
and 0.5% alginate gels, as well as between the 0.7% and 1.0% gels. All other pairs had
significantly different Young’s moduli.
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Fig. 2-10. Representative stress-strain curve of a 1.5% RGDalginate gel. The linear region is denoted at strain values ≥ 0.1.

The Young’s modulus values calculated for the 0.5%, 1.0%, and 1.5% RGDalginate gels were 5.10 ± 0.33, 12.78 ± 0.62, and 21.72 ± 2.00, respectively (n=20 per
concentration; Table 2-1). All three concentrations of RGD-alginate gels had
significantly greater Young’s modulus values than the corresponding concentrations of
unmodified alginate (p<0.05). The Young’s moduli for the unmodified alginate gels and
RGD-alginate gels are plotted together in Fig. 2.11, along with their corresponding linear
equations of best fit. A strong linear relationship was observed between Young’s
modulus and alginate concentration for both the unmodified and RGD-conjugated
alginate gels, with r2 values of 0.9375 and 0.9981, respectively (Fig. 2-11).
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Table 2-1. Young’s modulus values for unmodified alginate and RGDalginate hydrogels of increasing concentrations. Values with different letters
as superscripts differ significantly (p<0.05).

Alginate
concentration
(% w/v)

Young’s
Modulus
(KPa)

RGD-Alginate
Concentration
(% w/v)

Young’s
Modulus
(KPa)

0.375%

2.59 (± 0.20)a

-

-

0.5%

3.00 (± 0.15)a

0.5%

5.10 (± 0.33)d

0.7%

7.64 (± 0.51)b

-

-

1.0%

7.75 (± 0.46)b

1.0%

12.78 (± 0.62)e

1.5%

17.3 (± 0.85)c

1.5%

21.72 (± 2.00)f

Fig. 2-11. Young’s modulus as a function of alginate concentration for
unmodified (black circle) and RGD-modified (red triangle) alginate gels. The
plotted lines display the linear equations of best fit for both alginate conditions
(Unmodified alginate: r2 = 0.9375; RGD-alginate: r2 = 0.9981).

2.4. Discussion
In the present study, several aspects of alginate gel design were investigated and
characterized, demonstrating alginate’s potential as a 3-D matrix for in vitro cell and
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tissue models. First, various methods of gel formation were developed to produce
alginate gels of distinctive forms. Alginate has been widely used in cell/tissue
encapsulation studies, but previous studies have mainly involved microencapsulation
processes, producing alginate beads on the micro scale for cell [101-103] and small tissue
[33, 36, 38] encapsulation. In contrast, the methods described here produced gels on a
millimeter scale, which can be used for large tissue models such as the pig embryo model
[50] and growth plate model described later in this thesis. Previous studies investigating
the uniformity of 500-µm alginate beads created by the external gelation method used
fluorescently labeled alginate to demonstrate that bead formation results in a radially
inhomogeneous distribution of alginate, with the least amount of crosslinking located in
the gel core [104, 105]. Adding a non-gelling salt, such as sodium chloride, to the CaCl2
crosslinking solution results in greater uniformity, yet an inhomogeneous distribution of
alginate still occurs [104]. This inhomogeneous distribution is most likely increased in
the beads made using the methods of this study, due to the large size of the beads (2-3
mm). However, for the pig embryo project, which requires a large gel for encapsulation,
this result is preferred due to a more permissive core for growth and a stiffer outer region
for stability.
A method for creating cylindrical alginate gels was also established in this study.
Previous studies involving cylindrical alginate gels have employed the internal gelation
method to create the gels [15, 106, 107], in which a calcium slurry, usually calcium
carbonate or calcium sulfate (CaSO4), is mixed into the alginate solution and gelation
occurs as the calcium slowly leaks from within the alginate [11]. In this case, release of
the calcium is caused by a reduction in pH that may be harmful to cells that are within the
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alginate solution during gelation [11]. The method described in this report for creating
cylindrical alginate gels instead uses the external gelation method, involving CaCl2,
which would not have the harmful effect on cell viability. Furthermore, like the bead
method, the cylindrical gel method in this study involves radial diffusion of calcium ions;
however, the radial diffusion only occurs transversely to the center of the gel. Therefore,
the cylindrical gels created in this study most likely contain an inhomogeneous
distribution of crosslinking in the transverse direction, with a core axis throughout the
length of the gel that has the lowest degree of crosslinking due to hindered diffusion. This
permissive central area may serve to guide embryo/tissue growth in the longitudinal
direction when cells or embryos are encapsulated within the gel.
Another approach to maintaining tissue architecture is to provide a physical
reservoir to direct tissue or embryo growth by creating an environment within the gel in
which the tissue or embryo can be inserted post-crosslinking. With the both alginate tube
and well methods, the surrounding hydrogel tube or well can serve as a physical structure
to potentially direct tissue growth within the hollow cavity. The tubular gels, in
particular, could serve in multiple applications, as cells can be seeded inside the lumen
and/or encapsulated within the walls of the tube. Previously, studies establishing methods
for the creation of tubular alginate gels on a similar scale as the ones presented in this
study have involved complex mechanisms, such as laser-assisted printing [108] and
electrodeposition [109]. In contrast, the method described in this study offers a simple,
gentle process for the creation of alginate tubes. Furthermore, this report is the first to
demonstrate the formation of wells within alginate. Using the row of wells, embryos
could be cultured in individual alginate wells yet within the same culture dish to observe
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any embryo-embryo interactions in vitro without direct contact. Additionally, the row of
wells can be easily cut to produce separated wells for individual embryo culture.
In addition to gel formation, chemical modification of alginate was investigated in
the present study, specifically the covalent attachment of an RGD peptide to the alginate
polymer backbone. The RGD peptides serve as ligands to cell integrins, which are cellsurface receptors that integrate with the ECM to mediate cell migration and adhesion [1].
As alginate is naturally an inert polymer that is not conducive to cell adhesion [14], a cell
adhesion study can serve as an indirect method of confirming successful conjugation of
the peptide. The GRGDSP-modified alginate gels promoted cell adhesion and slow
proliferation of D1 ORL UVA cells, forming aggregated cell clusters over time. In
contrast, the unmodified alginate gels promoted little to no cell adhesion. These results
suggest that the peptide was successfully conjugated to the alginate backbone. The results
of the GRGDSP-alginate gels support previous studies that used similar methods of RGD
peptide conjugation to promote cell adhesion [14, 27]. These studies found that low RGD
peptide densities promoted cell adhesion, slow proliferation, and aggregation into
clusters, as seen with the gels of the present study; however, spreading and proliferation
increased with increasing RGD peptide densities [27]. Therefore, future studies could
investigate higher RGD peptide densities to increase proliferation effects and overcome
clustering. Successful peptide conjugation was further confirmed by 1H-NMR
spectroscopy, which has previously been used to confirm RGD peptide conjugation to
polymers [100]. For tissue engineering applications, the unmodified alginate gels can
serve to solely provide 3-D support for cell/tissue growth, while the RGD-alginate gels
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can function to promote cell-matrix interactions via cellular adhesion and
mechanotransduction [110].
Stiffness, in particular Young’s modulus, of alginate gels was another property
that was investigated in this study. Stiffness is the most common mechanical cue
experienced by cells, with a range of 0.1 kPa to 40 kPa for native soft tissues [111]. The
results of the present study demonstrate that alginate gels made with our methods are
within this stiffness range, validating the use of alginate as a 3-D matrix to mimic native
soft tissues [6]. Furthermore, the results of this study demonstrate that Young’s modulus
increases with increasing alginate concentration following a linear trend, which supports
results found in previous studies [15]. Surprisingly, we found that GRGDSP conjugation
to alginate resulted in Young’s moduli that were significantly greater than unmodified
gels of the same concentrations, despite the fact that RGD peptide conjugation lowers the
amount of carboxyl groups available for ionic crosslinking. These results were
unexpected, as a previous study demonstrated that low RGD peptide concentrations did
not have a significant effect on compression modulus and that higher amounts of peptide
conjugation resulted in a lower modulus [112]. The Young’s moduli for both alginate
conditions, however, are all within the stiffness range of native soft tissue and the largest
difference detected between the unmodified and modified alginate gels was only ~5 KPa.
It is also important to note that the unmodified alginate used in these studies was not
subjected to the same buffer dissolution and subsequent lyophilization process as the
peptide-conjugated alginate, which could serve as a reason for the difference in
mechanical properties between the resulting gels.
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In conclusion, this study demonstrates that alginate hydrogels can be easily
manipulated in regards to gel formation, bioactive properties, and mechanical properties,
making it a suitable material for use as a 3-D matrix in in vitro culture models. Each of
the characteristics explored in this study can be tested for its effect on embryo
development for the in vitro pig embryo model described in Chapter 3, as well as for its
effect on chondrocyte function and arrangement for the in vitro growth plate model
described in Chapter 4. Optimal gel conditions can then be determined in order to
establish in vitro models that best mimic in vivo conditions, in order to evaluate factors
and mechanisms involved in normal and abnormal development; knowledge of these
mechanisms could be used to enhance strategies for increasing pregnancy outcomes (pig
embryo project) and for engineering growth plate cartilage with proper architecture and
function (growth plate project).
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CHAPTER 3
In vitro development of pre-implantation porcine embryos using alginate hydrogels
as a three-dimensional extracellular matrix

3.1. Introduction
In the pig, the pre-implantation period of pregnancy is characterized by several
developmental hallmarks. Between day 10 and 12 of gestation, the porcine embryo
undergoes a process known as elongation, transforming from a ~1-mm spherical structure
to a long, thin filament >100 mm in length [113, 114]. Unlike elongation in other
domestic species, rapid elongation of the pig embryo occurs via cellular remodeling and
differentiation of the trophectoderm rather than cellular hyperplasia [113, 114]. During
elongation, the embryo produces and secretes estrogen, which serves as a key molecular
signal for maternal recognition of pregnancy and modulates the production of proteins
and growth factors within the uterus [115]. Adequate elongation and successful
implantation of the porcine embryo subsequently affect embryo spacing in the uterus,
placental development, and fetal growth, which have implications on uterine capacity,
litter size and postnatal piglet health [78, 116].
Approximately 20 percent of embryonic loss occurs during the pre-implantation
period of pregnancy in the pig, with a significant portion of these losses occurring due to
deficiencies in embryo elongation [77]. Early embryonic loss is poorly understood
because exact physiological mechanisms by which the embryo elongates, and how these
mechanisms are altered during embryonic loss, are not clear. Developing details of the
mechanisms that regulate embryo elongation can allow for identification of specific
biophysical, biomechanical, and molecular factors that could serve as targets for
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improving pregnancy outcomes and neonatal piglet survival. An effective in vitro culture
system that supports pig embryo elongation could be used to evaluate specific
mechanisms of elongation. To date, attempts to initiate elongation in porcine embryos in
vitro have been unsuccessful compared to other livestock species [81]. In cattle, limited
elongation of embryos in vitro via physical induction was demonstrated using an agarose
gel tube system [48, 49, 80]. However, embryos cultured in this system had deficiencies
in the development of the embryonic disk [49, 81], which may have been the result of
forced growth of the embryos to fill the tubes. Nevertheless, attempts to repeat these
results using porcine embryos have been unsuccessful [81].
Alginate is a commonly used biomaterial, often employed as an artificial
extracellular matrix in tissue engineering applications [8]. Alginate is a linear
polysaccharide derived from brown algae composed of repeating units of β-D-mannuronic
acid and α-L-guluronic acid [117]. One of the favorable properties of alginate as a
biomaterial is its ability to form a hydrogel by ionic cross-linking of the guluronic
residues in the presence of a divalent cation [118]. The alginate gel forms a mesh-like
structure that permits diffusion of nutrients and hormones essential for cell and tissue
growth and development [117]. Furthermore, alginate promotes negligible non-specific
protein adsorption and cell adhesion, making it a suitable material for solely examining
mechanical influence on tissue morphogenesis [14, 119]. We hypothesize that previous
failure of porcine embryos to elongate in vitro is, at least to an extent, due to inadequate
culture systems lacking three-dimensional (3-D) structure for proper biomechanical
support of embryo elongation. Traditional two-dimensional (2-D) cultures result in a
disruption of cell-to-cell interactions as cells attach to the substrate and migrate away
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from the tissue [33, 45]. Three-dimensional culture systems, alternatively, can maintain
embryo architecture and allow for direct physical interaction with the surrounding
environment, which better mimics in vivo development. Therefore, our objective was to
use alginate hydrogels to establish an in vitro culture system based on tissue engineering
principles (i.e. 3-D scaffolds) that can mechanically support the culture of preimplantation porcine embryos, ensure proper internal biomechanics, and initiate
morphological changes. In the present study, in vitro development was evaluated by
characterizing cellular survival, morphological changes, gene expression of steroidogenic
and immunological transcripts, and estradiol 17-β (E2) production from porcine embryos
encapsulated (ENC) in alginate hydrogels or remaining as non-encapsulated controls
(CONT).

3.2. Materials and methods
3.2.1. Production and collection of embryos
All animal protocols were approved by the USMARC Animal Care and Use
committee and met the USDA guidelines (1995) for the care and use of animals. Fifteen,
normally cycling White crossbred gilts consisting of Landrace, Yorkshire and Duroc
genetics were checked daily for estrus. Following first detection of estrus (designated as
d 0), gilts were artificially inseminated with semen from a single Duroc sire with three
sires represented across the replicate collections (International Boar Semen, Inc., Eldora,
IA) and again 24 h later with the same sire. In three independent replicate collections,
five gilts were slaughtered at the USMARC abattoir at d 9, 10, or 11 of gestation.
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Following slaughter, reproductive tracts were removed immediately and each uterine
horn was flushed with 20 mL (~37º C) of Hepes-buffered RPMI-1640 media (Invitrogen,
Carlsbad, CA) containing 1x antibiotics/antimycotics (Sigma-Aldrich, St. Louis, MO).
Embryos were recovered and classified according to size and morphology using a
standard stereomicroscope. Embryos were then washed with Hepes-buffered RPMI-1640
media containing 1x antibiotics/antimycotics and 10% heat-inactivated fetal bovine
serum (FBS; Invitrogen). From homogenous litters, spherical embryos (~1 mm in
diameter with a range of 0.5 to 1.5 mm) recovered from gilts at d 9 of gestation (n = 3
gilts per replicate) were randomly assigned to the in vitro culture treatments (ENC or
CONT); a subset of these embryos were collected and snap frozen individually in liquid
nitrogen to serve as initial in vivo-produced spherical control embryos for transcript
expression. From homogenous litters, ovoid (5-10 mm in diameter) or tubular (>10 mm
in diameter with a range of 11 to 20 mm) embryos from the remaining gilts were
recovered at d 10 or 11 of gestation, respectively (n = 1 gilt per day per replicate) and
snap frozen individually in liquid nitrogen to serve as later-stage in vivo-developed
control embryos for transcript expression. Uterine flushings from all pregnant gilts were
collected, centrifuged to remove cellular debris and stored at -20°C for later E2 and
protein analysis.

3.2.2. Embryo encapsulation and culture
Embryos assigned to the ENC group were encapsulated within alginate hydrogels,
using a double encapsulation method (Fig. 3-1). Briefly, sodium alginate (Pronova UP
MVG, >60% guluronic acid, 200,000 – 300,000 g/mol, NovaMatrix, Norway) was
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dissolved in sterile MilliQ water to a final concentration of 0.7% (w/v). Droplets of
warmed, sterile alginate solution were placed onto polystyrene culture dishes. A single
embryo was pipetted into each droplet of alginate in a minimal amount of media as not to
dilute the alginate solution. Each droplet was then pipetted into a warmed, sterile crosslinking solution (50 mM CaCl2, 140 mM NaCl) and allowed to gel for 3 minutes.

Fig. 3-1. Schematic illustration of the double encapsulation method. 1) Embryo is
transferred into alginate droplet. 2) Droplet is pipetted into calcium solution. 3)
Alginate bead forms around embryo. 4) Alginate bead is transferred to larger droplet of
alginate. 5) Droplet with bead is pipetted into calcium solution. 6) Second layer of
alginate forms around embryo. Following encapsulation, all embryos were washed and
cultured individually in a single well within 4-well NUNC plates.

The resulting alginate beads with encapsulated embryos were then rinsed twice in
Hepes-buffered RPMI-1640 media containing 1x antibiotics/antimycotics and 10% FBS.
Following the rinse, each bead was encapsulated in a second layer of alginate, using
identical methods as described above for the initial encapsulation, to ensure complete
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encapsulation of each embryo. The final resulting beads were then washed once with
pre-gassed culture media containing RPMI-1640, 1x antibiotics/antimycotics and 10%
FBS. ENC and CONT embryos were cultured in individual wells in 4-well NUNC plates
(Thermo-Scientific, Rochester, NY) with 1 mL of culture media for 96 h at 38.5°C and
5% CO2 in air with 100% humidity.

3.2.3. Characterization of embryo viability and morphology
Every 24 h, an image was recorded of each embryo by photographing with a
SMZ1500 stereomicroscope (Nikon Instruments, Inc., Melville, NY). Based on visual
appraisal of these images, embryos were classified into one of three in vitro treatment
groups: CONT (non-encapsulated control embryos), ENC- (encapsulated embryos with
no observable morphological change) or ENC+ (encapsulated embryos with observable
morphological changes). Embryos undergoing morphological changes were
characterized by a tubular formation of the embryo within the gel and subsequent
flattening of this tube with many of these embryos migrating out of the gel forming a
secondary spherical structure once freely in the culture media (Fig. 3-2C). At the
termination of culture, embryo survival was determined by assessment of blastocyst
fragmentation. Surviving embryos were characterized with no apparent sign of cellular
degeneration, whereas dying embryos had significant cellular degeneration resulting in
blastocyst compaction and darkening of the embryo. Embryo survival and death were
confirmed in a subset (n = 10) of embryos using a fluorescein/ethidium bromide live/dead
staining protocol previously reported [120]. Live/dead staining (green or red,
respectively) was examined and imaged using an Axioplan2 fluorescence microscope
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(Zeiss, Inc., New York, NY).

Fig. 3-2. Representative illustration of morphological changes observed over 96 h of culture in
embryos double encapsulated in 0.7% alginate hydrogels or remaining as non-encapsulated control
embryos, with corresponding cellular survival and death after 96 h of culture. Surviving embryos that
remained intact with no signs of cellular degeneration were classified into one of three in vitro
treatment groups: A. CONT (non-encapsulated control embryo with no observable morphological
change), B. ENC- (encapsulated embryo with no observable morphological change) or C. ENC+
(encapsulated embryo with observable morphological changes). CONT (D.) and ENC- (E.) embryo
that underwent significant cellular death are characterized with significant cellular degeneration
resulting in blastocyst compaction and cellular darkening. The same representative embryo from each
treatment group is displayed across the different time points of culture and the live/dead staining.
Black and white scale bar = 1 mm corresponding to morphological images and live/dead staining,
respectively. Note, the morphological changes of the ENC+ embryo characterized by a tubular
formation of the embryo at 48 h that flattens by 72 h resulting in the embryo migrating out of the
hydrogel by 96 h. There were no observable differences in cellular survival (green stain) or death (red
stain) between surviving embryos in the three treatment groups (A., B., and C.); however, a greater
proportion of dead cells (red stain) were observed in the embryos classified as undergoing cellular
death (D. and E.).

	
  
3.2.4. Transcript expression analysis
At the termination of the 96-h culture period, all embryos were imaged prior to
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snap freezing in liquid nitrogen. CONT embryos were frozen in a small volume of
culture media (~5 µL), whereas ENC embryos were frozen within the alginate hydrogels.
Preliminary analysis of RNA quality following extraction demonstrated no difference
when embryos remained encapsulated in the hydrogel vs. de-encapsulating the embryos
prior to collection and extraction (data not shown). Whole-cell RNA (wcRNA) was
extracted from individual embryos that survived (i.e., remaining intact with no cellular
degeneration observed) throughout the duration of culture using the RNeasy Microkit
(Qiagen, Valencia, CA) with on-column DNase-I treatment as described by the
manufacturer. At the same time, wcRNA was extracted from in vivo-developed control
embryos (i.e., spherical, ovoid and tubular) that had previously been collected.
Quantification of the wcRNA was performed with RiboGreen as indicated by the
manufacturer (Molecular Probes, Inc.; Eugene, OR).
Using porcine-specific primers previously validated to amplify mRNA specific
for the long form variant of steroidogenic acute regulatory protein (STAR), cytochrome
P450 side chain cleavage (CYP11A1), aromatase (CYP19A1), and interleukin-1β (IL1B)
[121, 122], transcript expression levels were assessed using a two-step, real-time
quantitative PCR (qPCR) method with a Chromo4 real-time PCR detection system (BioRad, Hercules, CA). Briefly, reverse transcription was performed with 1 ng of wcRNA
from the in vivo-developed controls (i.e., spherical, n = 7; ovoid, n = 11; tubular, n = 6),
CONT (n = 7), ENC- (n = 13), and ENC+ (n = 9) using the iScript cDNA Synthesis kit
(Bio-Rad) according to the protocol of the manufacturer. In addition, a pooled sample of
wcRNA consisting of 1 ng of wcRNA from all embryo treatment groups represented was
reversed transcribed to generate a pooled cDNA sample that was used to generate a
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relative standard curve of cDNA for determining interassay CVs and relative quantity
(RQ) of transcript expression. Each qPCR was assayed in duplicate and consisted of 50pg equivalents of cDNA, 0.25 µM of the appropriate forward and reverse primers, and
12.5 µL of 1x iTaq SYBR Green Supermix with ROX (Bio-Rad) in a 25-µL reaction. All
PCR conditions included denaturation (95ºC for 2 min) followed by amplification (95ºC
for 15 sec, 60ºC for 15 sec and 70ºC for 45 sec) for 40 cycles. Melt-curve analysis and
gel electrophoresis were used to confirm amplification of a single product of the
predicted size.
Expression levels for each transcript were based on the threshold cycle (CT)
values determined using the Opticon Monitor 3 software (Bio-Rad). For each transcript,
two assays were performed containing equal representation of all embryo treatment
groups and a standard serial dilution of pooled cDNA consisting of 200-pg, 50-pg, 12.5pg, 3.12-pg and 0.78-pg equivalents of cDNA. After converting the exponential CT to the
linear CT using the formula 2-CT [123], the interassay CV for each transcript was
determined using the pooled cDNA samples from each assay and the intraassay CV for
each transcript was an average of all samples from both assays. The inter- and intraassay CVs for STAR were 19.3% and 18.8%, respectively; CYP11A1 were 16.1% and
18.0%, respectively; CYP19A1 were 14.9% and 20.0%, respectively; and IL1B were
7.3% and 20.4%, respectively. Calculation of the RQ value was determined using a
relative standard curve method by plotting treatment CTs against the logarithmic values
of standard amounts of pooled cDNA [124]. RQ values are expressed as arbitrary units.
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3.2.5. Estradiol-17β and protein assays
Every 24 h, half the culture media (500 µL) in each well was collected, stored at 20°C for hormone and protein analysis, and exchanged with fresh pre-gassed culture
media (500 µL). In addition, wells of culture media alone (MEDIA) were included in
each replicate and processed similarly to wells containing embryos. Estradiol-17β and
protein analyses were performed on culture media at 24, 48, 72 and 96 h from MEDIA (n
= 8) and cultures containing embryos represented in the qPCR analysis (i.e., CONT, n =
7; ENC-, n = 13; ENC+, n = 9). In addition, independent analyses for E2 and protein
were performed on uterine flushings collected from pregnant gilts at d 9 (n = 9), 10 (n =
3) and 11 (n = 3). Culture media and uterine flushings were measured for E2 using a
radioimmunoassay procedure previously described and validated in swine [121, 125].
Culture media were ether extracted and measured for E2 in duplicate in one assay with an
intraassay CV of 12.1%. Uterine flushings were ether extracted and measured for E2 in
duplicate in one assay with an intraassay CV of 13.0%. In addition, culture media and
uterine flushings were measured for total protein content using a bicinchoninic acid
protein assay (Pierce, Rockford, IL). Protein content in culture media was measured in
duplicate in six assays with inter- and intra-assay CVs of 9.3% and 7.7%, respectively.
Protein content from uterine flushings was measured in duplicate in one assay with an
intraassay CV of 2.4%.

3.2.6. Statistical Analysis
Proportional data for embryo survival and morphological changes following
culture were analyzed using the Chi-square test and were reported as least-squares means
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± standard error of the mean (LSM ± SEM) after calculating with GLIMMIX model
procedures [126, 127]. Transcript expression data, culture media E2 and protein levels,
and uterine flushing E2 and protein levels were analyzed using MIXED model
procedures and results are reported as LSM ± SEM [126, 127]. When a significant Fstatistic was generated, means were separated using Dunnett’s multiple comparison test
[126, 127]. Means were considered statistically different at P ≤ 0.05 and tendencies
between P = 0.06 and P = 0.10. Transcript expression data were categorized into 6
treatment groups corresponding to in vivo-developed spherical, ovoid and tubular
embryos and in vitro-cultured CONT, ENC- and ENC+ embryos and the model included
the fixed effects of treatment, replicate and the random effect of gilt within treatment.
Culture E2 and protein data were categorized into 4 treatment groups (i.e., MEDIA,
CONT, ENC- and ENC+) and the model included the fixed effects of treatment, culture
time, replicate, treatment by culture time interaction, and the random effect of gilt within
treatment by culture time interaction. Uterine flushing E2 and protein data were analyzed
with the model including day of gestation, replicate and the random effect of sire within
day of gestation. To remove skewness and normally distribute the data, all transcript
expression and E2 data were log-transformed prior to statistical analysis and backtransformed to report observed means.

3.3. Results
3.3.1. Evaluation of embryo viability and morphology
Figure 3-2 displays representative morphological changes observed over 96 h of
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culture of CONT and ENC embryos and their corresponding cellular survival and death
observed by live/dead staining after 96 h of culture. The assessment of blastocyst
degeneration at the termination of culture indicated that there was no significant
difference (P = 0.22) in survival between the CONT and ENC embryos (Table 3-1).
Embryo survival and death were further confirmed by live/dead staining a subset of
embryos, which demonstrated no observed differences in cellular survival or death
between treatment groups. Embryos classified as undergoing cellular degeneration had a
greater proportion of dead cells (red) while surviving embryos had a greater proportion of
live cells (green) (Fig. 3-2). Morphological changes were only observed in the ENC
embryos (Fig. 3-2C), while all CONT embryos remained spherical throughout the culture
period (Fig. 3-2A; Table 3-1). The percentage of embryos that underwent morphological
changes was significantly different between CONT and ENC groups when analyzing all
cultured embryos (P < 0.05) and only those embryos surviving (P < 0.001; Table 3-1).
The morphological changes observed in the ENC embryos were characterized by a
tubular formation of the embryo within the gel and subsequent flattening of this tube with
many of these embryos migrating out of the gel forming a secondary spherical structure
once freely in the culture media (Fig. 3-2C). Although 32% of the surviving ENC
embryos underwent morphological changes, a significant proportion of ENC embryos
remained spherical throughout culture (Fig. 3-2B). As a result, encapsulated embryos
were further classified as encapsulated embryos with no morphological changes (ENC-)
or encapsulated embryos with morphological changes (ENC+).
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Table 3-1. Summary of embryo survival and observed morphological changes following 96 h of
culture of either non-encapsulated control porcine embryos (CONT) or porcine embryos double
encapsulated (ENC) in 0.7% alginate hydrogels1

n (embryos)
Embryo survival (%)2
No morphological change from all
embryos (%)
Morphological change from all
embryos (%)
Morphological change from surviving
embryos (%)

CONT

ENC

P-value

24

71

33.3 ± 9.6 (8)

47.8 ± 5.9 (34)

0.22

100

83.1 ± 4.4

0.03

0

16.9 ± 4.4

0.03

0

32.3 ± 8.0

<0.001

1

Values are reported as least-squares means ± SEM as determined using GLIMMIX analysis for the main
effect of treatment (i.e., control vs. encapsulated embryos). Significance for the effect of treatment was
determined using Chi-square analysis.
2
Assessed by lack of blastocyst degeneration. Numbers in parentheses indicate the number of surviving
embryos for each treatment group.

3.3.2. Transcript expression levels
The expression of STAR mRNA was increased (P < 0.05) in all in vitro treatment
groups (CONT, ENC- and ENC+) compared to the initial in vivo spherical control (Fig.
3-3A). However, STAR expression was greater (P < 0.05) in ENC+ embryos compared
to ENC- embryos and tended to be greater (P = 0.07) in ENC+ embryos compared to
CONT embryos (Fig. 3-3A). As a result, the expression pattern of STAR in CONT and
ENC- embryos was more similar to in vivo ovoid embryos, whereas ENC+ embryos
displayed an expression pattern of STAR more similar to that of in vivo tubular embryos
(Fig. 3-3A). Expression levels of CYP11A1 mRNA were increased (P < 0.05) in all in
vitro treatment groups (CONT, ENC- and ENC+) compared to their initial in vivo
spherical controls (Fig. 3-3B). Furthermore, CYP11A1 expression was greater (P < 0.05)
in ENC+ embryos compared to CONT and ENC- embryos. Again as observed with
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STAR, the expression pattern of CYP11A1 in CONT and ENC- embryos was more similar
to in vivo ovoid embryos, whereas ENC+ embryos displayed an expression pattern of
CYP11A1 more similar to that of in vivo tubular embryos (Fig. 3-3A).

Fig. 3-3. Expression levels of A. STAR, B. CYP11A1, C. CYP19A1 and D. IL1B mRNA
measured by qPCR from in vivo-produced control embryos and in vitro-cultured CONT (nonencapsulated control), ENC- (encapsulated with no observable morphological changes) and
ENC+ (encapsulated with observable morphological changes) embryos. Data were logtransformed before analysis and back-transformed to observable values. Least-squares means
± SEM values are expressed as a relative quality (RQ). Statistical analysis demonstrated that
embryo treatment had significant effects on the expression level of A. STAR (P < 0.01), B.
CYP11A1 (P < 0.001), C. CYP19A1 (P < 0.01) and D. IL1B (P < 0.01). RQs with different
superscripts for each transcript are significantly different (P < 0.05).

	
  
Expression levels of CYP19A1 mRNA were greater (P < 0.05) in ENC+ embryos
compared to CONT and ENC- embryos (Fig. 3-3C). In addition, ENC+ embryos had an
expression level of CYP19A1 significantly greater (P < 0.05) than in vivo spherical
controls, whereas CYP19A1 expression levels were not different between CONT, ENC-
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and in vivo spherical controls (Fig. 3-3C). Furthermore, expression of CYP19A1 was
decreased (P < 0.05) in CONT and ENC- embryos compared to in vivo ovoid and tubular
embryos (Fig. 3-3C). In contrast, CYP19A1 expression did not differ between ENC+ and
the later-stage in vivo ovoid and tubular embryos, although the expression pattern was
numerically more similar in ENC+ and in vivo ovoid embryos (Fig. 3-3C). No
significant differences were detected in expression levels of IL1B mRNA between
CONT, ENC- and in vivo spherical controls (Fig. 3-3D). However, IL1B expression was
increased in the ENC+ embryos compared to CONT and in vivo spherical controls (Fig.
3-3D). Furthermore, expression of IL1B did not differ between ENC+ and in vivo ovoid
embryos, but was significantly (P < 0.05) decreased in ENC+ compared to in vivo tubular
embryos.

3.3.3. Estradiol-17β and protein analysis
A significant time-dependent increase (P < 0.001) in E2 levels in the culture
media of encapsulated embryos (both ENC+ and ENC-) was identified compared to
culture media from CONT embryos and culture media alone (Fig. 3-4A). Culture media
from all embryo groups (i.e., CONT, ENC- and ENC+) had greater (P < 0.05) E2 levels
than media alone after 96 h of culture (Fig. 3-4). Culture media containing ENC+
embryos had significantly greater levels (P = 0.05) of E2 compared to CONT and ENCembryos at 72- and 96-h time points (Fig. 3-4A). In contrast, culture media containing
ENC- embryos displayed an intermediate but significantly different (P < 0.05) level of E2
between ENC+ and CONT embryos at 96 h (Fig. 3-4A). A similar pattern of increased
(P < 0.05) E2 production was observed in uterine flushings as pregnancy progressed from

	
   62
9, 10 and 11 of gestation with the greatest levels of E2 in uterine flushings at d 11 of
gestation (Fig. 3-4B).

Fig. 3-4. A. Estradiol-17β (E2) concentrations (pg/mL) in culture media collected at 24-, 48-, 72- and 96h of culture containing only media (MEDIA), non-encapsulated control embryos (CONT), encapsulated
embryos with no observable morphological change (ENC-) and encapsulated embryos with observable
morphological changes (ENC+). B. E2 concentrations (pg/mL) in uterine flushings from pregnant gilts
at d 9, 10 and 11 of gestation. Data were log-transformed before analysis and back-transformed to
observed values and presented as least-squares means ± SEM. Statistical analysis demonstrated a
significant (P < 0.001) culture media treatment by culture time interaction for E2 concentration in which
culture media containing ENC+ embryos had greater E2 concentration compared to MEDIA, CONT and
ENC- groups at 72- and 96-h. Statistical analysis demonstrated a significant (P < 0.05) gestational day
effect for E2 concentration in uterine flushings.	
  

Results from the protein assay indicate that no significant differences were
detected for total protein levels in culture media containing MEDIA alone, CONT, ENC-,
or ENC+ embryos (Fig. 3-5A). In contrast, there tended (P = 0.09) to be a timedependent increase in total protein levels from uterine flushings as pregnancy progressed
from d 9, 10 and 11 of gestation (Fig. 3-5B).
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Fig. 3-5. A. Total protein (mg) in culture media collected at 24-, 48-, 72- and 96-h of culture containing
only media (MEDIA), non-encapsulated control embryos (CONT), encapsulated embryos with no
observable morphological change (ENC-) and encapsulated embryos with observable morphological
changes (ENC+). B. Total protein (mg) in uterine flushings from pregnant gilts at d 9, 10 and 11 of
gestation. Data are presented as least-squares means ± SEM. Statistical analysis demonstrated no
significant (P > 0.10) effects for total protein collected from the culture media at 24-, 48-, 72- and 96-h of
culture. Statistical analysis demonstrated a tendency (P = 0.09) for increased total protein in uterine
flushings at d 11 of gestation compared to d 9, with d 10 demonstrating an intermediate level of protein.	
  

3.4. Discussion
In the present study, alginate hydrogels were employed as 3-D matrices to support
in vitro culture of porcine embryos during the pre-implantation period. Previously,
alginate hydrogels have been used to support in vitro development of early blastocysts in
cattle [38], as an artificial zona pellucida for mouse morulae [128] and for the culture of
ovarian follicles in mice [15, 33, 37, 129] and nonhuman primates [34]. However, this
report is the first to demonstrate the use of alginate hydrogels for porcine embryo culture.
For those studies involving the encapsulation of early bovine embryos, 1.5% alginate
hydrogels supported similar blastocyst rates as 2-D controls; however, the alginate
system resulted in decreased blastocyst hatching rates, suggesting that the percentage of
alginate may have formed a matrix that was too rigid to allow for hatching [38]. Studies
involving mouse ovarian follicle culture investigated mechanical properties of alginate
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gels of varying concentrations and demonstrated that decreasing alginate matrix stiffness
enhanced follicle growth [15], linking biomechanical environmental factors with
cell/tissue development and function. Specifically, these studies demonstrated that 0.7%
alginate, the lowest concentration of alginate that was tested, formed a low-stiffness
hydrogel that was the most permissive to mouse follicle growth, cellular differentiation
and corresponding steroid production [15]. Based on these findings, 0.7% alginate was
used in the present study in order to provide sufficient mechanical support to properly
maintain porcine embryo development, without inhibiting growth or survival.
Our in vitro culture system utilizing alginate hydrogels was able to facilitate
morphological changes of pre-implantation porcine embryos by applying a tissue
engineering approach to embryo culture. Although survival rates did not differ between
the encapsulated and non-encapsulated embryos, morphological changes were only
observed with embryos encapsulated in alginate hydrogels. The inability of the nonencapsulated control embryos to undergo morphological changes in vitro suggests that a
3-D matrix is required to maintain appropriate embryo architecture for proper
development during the elongation stage of gestation. These results support the findings
of previous studies that demonstrated that both mechanical forces, generated from the
stiffness of surrounding tissues or substrates, and cell-generated contractility regulate
differentiation during embryonic development [96]. Our in vitro culture system
employing alginate hydrogel as a 3-D matrix may be initiating embryo morphological
change by stimulating biochemical signals within the embryo via mechanotransduction
[96, 97], or by simply providing support for the 3-D structure of the embryo to maintain
its cell-to-cell communication, a feature that traditional culture systems have been
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lacking. The requirement of the 3-D structure as a necessity to support morphological
changes can further be supported by the observation that when ENC+ embryos within our
culture system exited the alginate hydrogel, they formed a secondary spherical structure
likely due to fluid transport into the trophectoderm, which was observed in the nonencapsulated CONT embryos that did not have 3-D support.
Though the percentage of total encapsulated embryos that exhibited
morphological changes (17%) may seem lower than ultimately desired, it is important to
emphasize that if the encapsulated embryo survives within our newly developed in vitro
system, it has a relatively high chance of initiating morphological changes (32%) in
simple basal media conditions. In a previous study involving in vitro culture of bovine
embryos in agarose gel tunnels, high levels of glucose in the culture medium may have
resulted in rapid cell growth, contributing to the appearance of embryonic elongation
[49]. Conversely, in the present study, no particular growth factors or nutrients were
added to the culture medium, indicating that limited embryonic morphological changes
can occur in vitro within alginate hydrogels without the addition of special media
supplements. While the percentage of porcine embryos initiating morphological changes
in the current study is significantly less than reported in studies culturing bovine embryos
in the agarose gel tunnel system, ranging from 54% to 88% [48, 49, 80], it is important to
highlight that these bovine studies with a high percentage of morphological changes were
performed using embryos that were strictly produced in vitro and these embryos were
selectively chosen as high quality in vitro-produced embryos prior to being placed into
the agarose gel tunnel system [48, 49, 80]. In contrast, the current study only used in
vivo-produced embryos collected at d 9 of gestation in the pig. A previous study that
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investigated morphological changes using in vivo-produced bovine embryos within the
agarose gel system reported a very low percentage (3%) of in vivo-produced bovine
embryos that initiated morphological changes following in vitro culture in the agarose gel
system [82]. This finding, in conjunction with the findings of the current study,
illustrates that in vivo-produced embryos are not as efficient as in vitro-produced embryos
at initiating morphological changes within in vitro culture systems, which is likely the
result of the dramatic environmental change that in vivo-produced embryos experience
going from the uterine environment to an in vitro environment. Therefore, the percentage
of embryos that underwent morphological changes in the current study (i.e., 17%) is
relatively high for a study involving in vivo-produced embryos within an in vitro culture
system, with only basal culture media.
Several transcripts, such as steroidogenic transcripts (i.e., STAR, CYPY11A1 and
CYP19A1) and immune responsive transcripts (i.e., IL1B) are increased in a similar
pattern as estrogen production during embryo elongation [130, 131]. According to the
results of the present study, STAR expression levels for ENC+ embryos were similar to
tubular in vivo embryos, but greater than ovoid in vivo embryos. In contrast STAR
expression in CONT and ENC- embryos remained similar to ovoid in vivo embryos.
STAR, which is a major initiator of steroidogenesis [132], has previously been found to be
more abundantly expressed in elongated filamentous embryos than in ovoid embryos
[131]. Therefore, our STAR expression results suggest that embryos undergoing
morphological changes within alginate hydrogels exhibit similar STAR expression trends
as those that occur during initiation of elongation in vivo. Similar gene expression
patterns were found with CYP11A1 and CYP19A1 within our in vitro culture system,
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which are the two additional transcripts encoding for rate-limiting proteins required for
estrogen synthesis [131]. CYP11A1 and CYP19A1 expression levels were increased in
ENC+ embryos compared to CONT and ENC- embryos. These findings further suggest
that encapsulated embryos that transformed morphologically during culture also changed
at the level of gene expression, corresponding to the morphological transition and
differential steroidogenic gene expression that occurs during the onset of elongation in
vivo.
Proper interactions between the embryo and receptive uterine endometrium are
also essential for supporting embryonic development and subsequent implantation [67].
These interactions are initiated by the immune responsive cytokine IL1B, which is
increased by the embryo during elongation and may be responsible for preventing
conceptus rejection via suppressing the maternal immune response [67]. Although our
results demonstrate that the expression of IL1B was greater in ENC+ embryos compared
to CONT embryos, the expression pattern was decreased in the ENC+ compared to
tubular in vivo embryos. This outcome may suggest that direct interaction with the
maternal endometrium is likely required for up-regulation of IL1B in the embryo, while
up-regulation of steroidogenic transcripts may be independent of maternal-embryonic
cross-talk.
In vivo estrogen production by the porcine embryo increases during the elongation
stage, stimulating the synthesis and release of numerous endometrial secretory proteins,
which is essential for establishing maternal recognition of pregnancy [115, 130]. Our
results indicated that the ENC+ embryos produced and secreted a greater amount of E2
by 72 and 96 h of culture compared to the CONT and ENC- embryos. In addition, this
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up-regulation of E2 in the culture media of ENC+ embryos was independent of increased
production of total protein within the culture media. These results correspond with the
increased expression of steroidogenic transcripts STAR, CYP11A1, and CYP19A1 in the
ENC+ embryos, which supports previous findings of the direct correlation between these
transcripts and steroid synthesis [131, 132]. Therefore, the E2 results further suggest that
embryonic morphological changes induced by the alginate hydrogel culture system are
indications of initiation of elongation due to the corresponding increase in estrogen
production. The time-dependent increase in E2 observed in the culture media of ENC+
embryos followed a similar trend as observed for E2 levels in the uterine flushings as
pregnancy advanced through this time period, with the greatest production of estrogen
observed at d 11 of gestation when tubular embryos were present. Furthermore, protein
increased in the uterine flushings as pregnancy advanced. Given that protein increases
within the uterine milieu regardless of pregnancy status [133], increased expression of
steroidogenic transcripts and E2 production by ENC+ embryos without a difference in
protein levels within the culture media further suggests that up-regulation of
steroidogenesis and subsequent estrogen production may be independent of maternalembryonic cross-talk. It is important to highlight that there was a 48-h delay for
embryos cultured within alginate hydrogels to initiate production and secretion of E2 into
the culture media, as well as for significant morphological changes to occur, which
indicate a delay in development for in vitro-cultured embryos compared to in vivodeveloped embryos. A similar delay in morphological changes was observed in bovine
embryos cultured in the agarose gel system compared to in vivo-developed embryos [82].
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This delay is likely due to the embryos recovering from the encapsulation technique and
adjusting to the in vitro microenvironment.
Unlike elongation in other domestic animals, rapid elongation of the pig embryo
has been primarily associated with cellular remodeling and differentiation rather than
hyperplasia [61]. As a result, follow up studies investigating potential markers for
differentiation of the trophectoderm and mesoderm would be useful for measuring the
level of differentiation from embryos undergoing morphological changes within our in
vitro culture system. Furthermore, embryonic disc establishment, which was not
monitored in the current study, will be included in follow-up studies to further evaluate
the efficiency of our culture system. Monitoring the formation of the embryonic disc will
be a useful technique for measuring the synchrony between trophoblast and embryonic
disc development as we move forward to improve our in vitro culture system using
alginate hydrogels.
In conclusion, the present study demonstrates an in vitro culture system that can
support porcine embryo development during initiation of elongation. Our culture system,
which employs alginate hydrogel as a 3-D extracellular matrix for porcine embryo
culture, has proven to facilitate embryonic morphological changes with corresponding
increases in steroidogenic transcript expression and estrogen production, in a similar
pattern as observed in in vivo-developed embryos. Our findings advocate the potential of
our alginate culture system as an in vitro tool for evaluating and understanding specific
mechanisms of embryo elongation. Further investigations with our 3-D in vitro culture
system can focus on the effects of certain growth factors, hormones, ligands, and uterine
epithelial cell co-culture on development of pre-implantation porcine embryos. Specific
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factors regulating pig embryo elongation can be identified to develop strategies to
improve pregnancy outcomes in the pig. Identified factors could then be manipulated
through either direct intervention or marker-assisted selection of genomic markers to
improve early embryonic survival, uterine capacity, and pre-weaning piglet survival,
which could have a significant impact on the profitability of swine production.
Furthermore, our alginate culture system could be applied to embryos of other ungulate
species, such as cattle and sheep that also undergo embryo elongation during the preimplantation period of pregnancy, in order to identify potential regulators of normal
embryonic development in a variety of species.
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CHAPTER 4
The effect of parathyroid hormone and RGD peptide ligands on the in vitro
behavior of growth plate chondrocytes within 3-D alginate matrices
4.1. Introduction
Osteochondrodysplasias, a group of disorders characterized by abnormal growth
and remodeling of bone and cartilage, occur with over 200 different phenotypes, with a
prevalence estimated to be between 1 in 3000 to 1 in 5000 births [88]. Mutations
responsible for these dysplasias may cause defects in the synthesis of extracellular matrix
proteins, specific growth factors, receptors, and transcription factors, leading to short
stature and/or cranial defects [89]. Furthermore, skeletal growth can be affected by
defects in growth plate function due to radiation and chemotherapy as well as cartilage
injury from sports and high impact activities [134, 135]. In addition to affecting quality of
life, growth plate damage due to injury or disease is often associated with long-term
intensive health care needs due to impact on the joints, the central nervous system, and
the ocular system [90, 91]. As cartilage does not heal, strategies to replace damaged or
diseased cartilage through tissue engineering or regenerative approaches are of great
interest.
Within growth plate cartilage, chondrocytes differentiate in a spatially regulated
manner that results in morphologically and functionally distinct zones of cells, forming a
continuum from progenitor cells (resting chondrocytes) to terminally differentiated,
hypertrophic chondrocytes [83, 85] (Fig. 4-1). The middle proliferative zone is
distinguished by a columnar arrangement of flattened chondrocytes regulated by an
indirect, functional feedback loop between the secreted proteins parathyroid hormone
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related protein (PTHrP) and Indian hedgehog (Ihh), produced by resting and early
hypertrophic chondrocytes, respectively [83-85]. Prehypertrophic chondrocytes exiting
the proliferative columns express Ihh, which stimulates the production of PTHrP by
resting cells and perichondral cells located at the bone ends [83, 85].

Perichondral cells
Resting chondrocytes

Proliferative chondrocytes

PTHrP

Ihh

Type II collagen,
hyaline cartilage
matrix

Prehypertrophic chondrocytes

Hypertrophic chondrocytes

Type X collagen,
calcifying matrix

Fig. 4-1. Schematic illustration of zonal arrangement of chondrocytes and
Ihh/PTHrP feedback loop within the growth plate.

PTHrP receptors are expressed at low levels in chondrocytes of the proliferative
zone and high levels in the pre-hypertrophic chondrocytes as they transition from the
proliferative to hypertrophic state [83, 136]. PTHrP primarily acts to keep these cells in
the proliferative pool, delaying further differentiation [83, 137]. As chondrocytes in the
proliferative columns become too distant from the PTHrP-producing cells located at the
bone ends, PTHrP concentration becomes too low to stimulate them; this lack of
stimulation causes the chondrocytes to stop proliferating, enter a pre-hypertrophic
maturation phase, and begin to synthesize Ihh, thereby forming a feedback loop that
controls the length of the proliferative columns and site of hypertrophic differentiation
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[83, 137]. The chondrocytes of the resting and proliferating zones are also characterized
by the secretion of structural proteins, predominately type II collagen, while hypertrophic
cells primarily synthesize type X collagen and begin to remodel the cartilage matrix into
a calcifying matrix [83-85].
Although significant advances have been made in discovering signaling pathways
and gradients that regulate growth plate function, it remains unclear whether these factors
alone are sufficient to induce normal growth plate structure and function. Previous
attempts to engineer growth plate cartilage have failed to produce native cartilage
architecture, in particular a distinct zone of proliferating columnar chondrocytes,
suggesting that these factors are not enough to replicate proper structure in vitro.
Therefore, an effective in vitro model of the growth plate could serve as the necessary
tool for further evaluating specific mechanisms that regulate proper growth plate
structure and function. Understanding these mechanisms by studying the generation of
growth plate architecture in vitro is critical for enhancing tissue engineering strategies in
order to provide optimal replacement tissue for abnormal or damaged growth plates.
We hypothesize that a three dimensional (3-D) matrix with appropriate
biomechanics, extracellular matrix (ECM) factors, and signaling gradients can establish
an in vitro model of native growth plate cartilage. The objective of the current study was
to first investigate the effect of parathyroid hormone (PTH) on isolated mouse growth
plate chondrocytes in vitro, encapsulated within alginate hydrogels as the 3-D artificial
matrix. Alginate is a linear polysaccharide composed of repeating units of β-Dmannuronic acid (M) and α-L-guluronic acid (G) [9] that forms a hydrogel by ionic crosslinking of the G residues in the presence of a divalent cation [10]. In addition to its gentle
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gelation process and high porosity for diffusion of nutrients and growth factors [7, 13],
alginate promotes negligible non-specific protein adsorption and cell adhesion [14],
allowing alginate to act as a “blank slate” into which specific cell-matrix interaction
factors can be added. The arginine-glycine-aspartic acid (RGD) peptide sequence, which
is found in extracellular matrix proteins of cartilage such as collagen, fibronectin,
laminin, is the most effective and commonly used peptide sequence to promote cell
adhesion [43]. When covalently linked to alginate, RGD peptide sites serve as ligands to
cell integrins to mediate cell migration and adhesion. Therefore, RGD peptide
conjugation to alginate was the second factor investigated in this study for its effect on in
vitro growth plate chondrocyte behavior. In vitro chondrocyte behavior within
unmodified and RGD-conjugated alginate gels, with and without PTH treatment, was
evaluated by characterizing cellular proliferation and analyzing gene expression of
transcripts involved in chondrocyte hypertrophy.

4.2. Methods
4.2.1. Preparation of alginate solutions
For the unmodified alginate condition, sodium alginate (Pronova UP MVG, >60%
guluronic acid, 200,000 – 300,000 g/mol, NovaMatrix, Norway) was dissolved in sterile
1X phosphate buffered saline (1X PBS) to a final concentration of 1.5% (w/v). For the
RGD peptide treatment, alginate was covalently modified with a GRGDSP peptide
(Anaspec, Fremont, CA) to a concentration of 4 µmol/g alginate using carbodiimide
chemistry, as previously described [14]. Briefly, two grams of sodium alginate were
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added to 200 mL of MES buffer (0.1M MES, 0.3M NaCl, pH 6.5) and the alginate was
allowed to dissolve for 7-8 hours on a stir plate. 1-ethyl-(dimethylaminopropyl)
carbodiimide (EDC; Sigma Aldrich, St. Louis, MO) was added to activate 5% of the
uronic acids of the alginate polymer backbone in order to form amide linkages with the
peptide. To stabilize the reactive EDC intermediate against a competing hydrolysis
reaction, N-hydroxy-sulfosuccinimide (sulfo-NHS; Pierce, Rockford, IL) was also added
to the solution at a 2:1 EDC to NHS ratio. Lastly, the GRGDSP peptide was incorporated
into the solution, conjugating to the alginate backbone via the terminal amine of the
peptide. After 20 hours of reacting, the conjugation reaction was quenched through the
addition of hydroxylamine hydrochloride (Sigma Aldrich). The alginate solution was
then dialyzed against decreasing salt solutions and finally ddH2O over the course of 3
days. The final dialyzed solution was lyophilized to dryness and dissolved in 1X PBS to a
final concentration of 1.5% (w/v).

4.2.2. Isolation of growth plate chondrocytes
Growth plate cartilage was dissected from the distal growth plate of the femur and
the proximal growth plate of the tibia from three- and four-day-old neonatal Swiss
Webster mice. The growth plate cartilage was then incubated in 1 mL of 0.5%
collagenase in Dulbecco’s Modified Eagle’s Medium (DMEM; Invitrogen, Carlsbad,
CA) with 10% fetal bovine serum (FBS) for 3-4 hours at 37°C and 8% CO2, resulting in a
suspension of chondrocytes. Next, 10 mL of DMEM with 10% FBS was added to the
suspension of chondrocytes and centrifuged for 5 minutes at 125 x g. After aspirating the
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supernatant, the cell pellet was resuspended in 10 mL of DMEM with 10% FBS and cells
were counted with a hemacytometer.

4.2.3. Chondrocyte encapsulation and culture
Chondrocytes were cultured in four different treatment groups, as shown in Table
4-1: unmodified alginate gels without the addition of PTH (Unmodified/no PTH),
unmodified alginate gels treated with 1 µM PTH (Unmodified + PTH), GRGDSPconjugated alginate gels without the addition of PTH (RGD/no PTH), and GRGDSPconjugated alginate gels treated with 1 µM PTH (RGD + PTH). Prior to encapsulation,
chondrocytes were once again pelleted by centrifugation, resuspended in a volume of
culture media equal to 10% of the volume of alginate, and then mixed into the alginate
and RGD-alginate solutions to obtain a concentration of 8x106 cells/mL alginate. A
separate batch of cell/alginate suspension was prepared for each condition. To
encapsulate the chondrocytes, 10-µL drops of the alginate/cell mixture were placed one at
a time into crosslinking solution (50 mM CaCl2/140 mM NaCl) for 2 minutes, forming
cell-embedded alginate hydrogel beads. The beads were then transferred to wells of rinse
media to leach out excess calcium ions before being placed into fresh wells of cartilage
culture media (MEM alpha medium without Phenol Red [Invitrogen] supplemented with
50 µg/mL Penicillin-Streptomycin-Glutamine [Invitrogen], 10 mM β-glycerophosphate,
and 50 µg/mL ascorbic acid). For the PTH conditions, PTH (Sigma Aldrich) was added
to the culture media to obtain a final concentration of 1 µM. A total of 9 beads were made
per condition so that a subset of 3 beads could be analyzed at each time point (Table 4-1).
Additionally, 4 extra beads were made for the RGD/no PTH condition to perform
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live/dead staining, which will be described below. The beads were cultured for 3 days,
with the media replaced every 24 hours. Endpoint analyses were performed on Day 1, 2,
and 3 of culture as described in the following sections.
Table 4-1. Overview of number of beads per culture condition and per endpoint analysis.
Total number of beads per condition were divided up between the three time points (Days 1,
2, and 3) so that a subset could be taken on each day for analysis. Live/dead staining for the
RGD + PTH condition was performed on Day 1 for the first and last beads made for that
condition, and on a representative bead at Days 2 and 3.

4.2.4. Characterization of cell viability and proliferation
Because beads were made sequentially after blending the cells into the alginate
solution for each condition, some cells were required to remain in alginate solution longer
than others prior to crosslinking. To determine if this extra time spent in alginate solution
lowered cell viability, the first bead prepared from the batch of alginate/cell suspension
for the RGD/no PTH condition, along with the last bead prepared from this batch, were
live/dead stained after Day 1 of culture. Additionally, one representative bead from the
same condition (RGD/no PTH) was removed from culture on Day 2 and Day 3 for
live/dead staining to evaluate cell viability over the course of the culture period. These
beads were rinsed twice with 1X tris-buffered saline with 1.8 mM CaCl2 (1X TBS + 1.8
mM CaCl2) and then placed into 1xTBS with 2 µM calcein AM and 4 µM ethidium
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homodimer-1 for 30 minutes to stain live and dead cells, respectively. After another rinse
in 1X TBS + 1.8 mM CaCl2, the beads were placed on a glass coverslip and imaged using
an epifluorescence microscope (Leica DMI6000B, Wetzlar, Germany).
For analysis of cell proliferation on Days 1, 2 and 3 of culture, a subset of beads,
one from each condition, was analyzed using the Click-iT EdU Imaging kit (Invitrogen,
Carlsbad, CA), following manufacturer’s instructions. EdU (5-ethynyl-2’-deoxyuridine)
is a nucleoside analog of thymidine that becomes integrated into DNA during active
DNA synthesis, serving as a marker for cellular proliferation when covalently bound to a
fluorescent probe. Briefly, the encapsulated cells were incubated with EdU for 1 hour and
then fixed in 4% paraformaldehyde with 1.8 mM CaCl2. After rinsing in 1xTBS +1.8 mM
CaCl2, the beads were embedded in 6% agarose and then sectioned into 300-µm sections
within a 1xTBS + 1.8 mM CaCl2 bath using a vibratome (Leica). Sections were then
incubated in the Click-iT reaction cocktail consisting of an Alexa Fluor azide to detect
EdU incorporation. Finally, cellular DNA was stained with Hoechst 33342 to identify
nuclei. The cells were then imaged using an epifluorescence microscope (Leica
DMI6000B). The Volocity software (Perkin Elmer, Waltham, MA) was used to perform
deconvolution of z-stacks to remove background fluorescence and then used to count
total number of cells in each section (one section per condition), as well as cells that
stained positively for EdU, to determine percent proliferation.

4.2.5. Transcript expression analysis
Real-time PCR (RT-PCR) was used to analyze expression of collagen 10a1
(ColX), Indian hedgehog (Ihh), and Sox9 (Sox9; marker for chondrocyte differentiation)
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transcripts. At the specified time points, a subset of alginate beads from each condition
was taken from culture and dissolved in 50 mM EDTA for 10 minutes to release the cells
for RNA extraction. Total RNA was extracted using TRIzol reagent following the
manufacturer’s instructions (Invitrogen). Total RNA was then treated with DNase I
(Promega, Madison, WI) to remove any genomic DNA and reverse transcribed to cDNA
using SuperScript III Reverse Transcriptase (Invitrogen) and random primers (Promega)
combined with oligoDT20 primers (Invitrogen). Real-time PCR was performed using
ABsolute Blue Sybr Green ROX mix (Thermo Scientific, Waltham, MA) and a
StepOnePlus System (Applied Biosystems, Carlsbad, CA). Gene specific primers
designed for the genes specified above are shown in Table 4-2. Data were normalized to
an endogenous control, actin, using the primers shown in Table 4-2 for β-actin.
Table 4-2. Description of the designed primers.

Target

Forward Primer Sequence

Reverse Primer Sequence

Collagen 10a1 TTCTGCTGCTAATGTTCTTGACC GGGATGAAGTATTGTGTCTTGGG
Ihh

CCCCAACTACAATCCCGACA

TCATGAGGCGGTCGGC

Sox9

ACGGCTCCAGCAAGAACAAG

TTGTGCAGATGCGGGTACTG

ß-actin

AAATCGTGCGTGACATCAAAGA GCCATCTCCTGCTCGAAGTC

4.2.6. Statistical analysis
For RT-PCR results, RQ values are reported as mean ± standard deviation. After
normalizing to the endogenous control, data within each day were normalized to the
values for the unmodified/no PTH condition to observe treatment effects. One-way
analysis of variance (ANOVA) was used to determine if means were statistically
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different. If ANOVA analysis showed a significant difference among the means, Tukey’s
multiple comparison test was then used to perform pairwise comparisons.

4.3. Results
4.3.1. Evaluation of chondrocyte viability and proliferation
After 24 hours of culture, chondrocytes encapsulated in the first and last bead
prepared from the alginate/cell suspension for the RGD /no PTH condition were live/dead
stained and compared in order to assess whether extra time spent in alginate solution
prior to crosslinking affected cellular survival. No considerable differences in cellular
survival or death were observed between the first and last bead that were made for this
condition (Fig. 4-2A and 4-2B). In addition, no substantial differences in cell viability
were observed between Days 1, 2, and 3 of culture within the RGD-alginate gels (Fig. 42C and 4-2D).
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A.

Day 1 – First bead

B.

Day 1 – Last bead

C.

Day 2

D.

Day 3

Fig. 4-2. Live/dead staining at Day 1 of culture of chondrocytes
encapsulated in the first (A.) and last (B.) beads that were prepared from
the RGD/no PTH condition, and representative beads from this batch on
Day 2 (C.) and Day 3 (D.) of culture. No considerable differences in
cellular survival (green) or death (red) were observed between the first and
last bead on Day 1, or between Days 1, 2, and 3 of culture.

To identify the number of proliferating chondrocytes in each treatment group
(Table 4-1), 300-µm sections (one section per condition) were treated with EdU and
stained for EdU detection. Cellular DNA was then stained to evaluate total number of
cells in order to calculate the percentage of cells that were positive for EdU staining.
Representative images are shown in Figure 4-3 and calculated results are presented in
Table 4-3, with some treatments missing due to loss of sections. No substantial effects of
RGD ligands or PTH on percent proliferation were observed, as the percentages for each
treatment group only differed by a few percent at most (Table 4-3). However, despite the
low percentages for all conditions, the RGD-alginate condition had an approximately 2.5fold higher percent proliferation by Day 3 compared to the corresponding unmodified
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alginate condition (Table 4-3), and the PTH treatment groups exhibited a 1.3- to 1.5-fold
higher percent proliferation by Days 2 and 3 compared to the corresponding gel
conditions without the addition of PTH (Table 4-3).
Day 1 – RGD/no PTH

Day 1 – RGD + PTH

Day 1 – Unmodified + PTH

Day 2 – RGD/no PTH

Day 2 – RGD + PTH

Day 2 – Unmodified/no PTH

Day 3 – RGD/no PTH

Day 3 – Unmodified/no PTH

Day 3 – Unmodified + PTH

Fig. 4-3. Representative images of nuclear (blue) and EdU (green) staining of chondrocytes
cultured in unmodified alginate gels without PTH (Unmodified/no PTH), unmodified gels
with 1 µM PTH (Unmodified + PTH), RGD-alginate gels without PTH (RGD/no PTH), and
RGD-alginate gels with 1 µM PTH (RGD + PTH). No considerable differences in percent
proliferation (i.e. percent EdU positive) were observed.

RGD
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Table 4-3. Proliferation results of chondrocytes cultured in unmodified or RGDalginate gels, with or without PTH added to the culture media. Percent
proliferation, i.e. %EdU positive, is based on the ratio of cells that stained positive
for EdU to total number of cells (determined by nuclear Hoechst staining). Dashes
represent sections that were lost during the staining process.
Day
Sample
EdU,Positive
Cell,Count %,EdU,Positive
Day$1
RGD/no$PTH
92
2114
4.35%
Day$1
RGD$+$PTH
29
2793
1.04%
Day$1
Unmodified/no$PTH
>
>
>
Day$1
Unmodified$+$PTH
81
2539
3.19%
Day$2
RGD/no$PTH
61
4003
1.52%
Day$2
RGD$+$PTH
42
2080
2.02%
Day$2
Unmodified/no$PTH
7
588
1.19%
Day$2
Unmodified$+$PTH
>
>
>
Day$3
RGD/no$PTH
58
2848
2.04%
Day$3
RGD$+$PTH
>
>
>
Day$3
Unmodified/no$PTH
33
3988
0.83%
Day$3
Unmodified$+$PTH
16
1315
1.22%

4.3.2. Transcript expression levels
On Day 1 of culture, expression of ColX (Fig. 4-4A) was statistically greater
(p<0.05) in chondrocytes encapsulated in RGD-alginate compared to chondrocytes
encapsulated in unmodified alginate, when no PTH was added to either condition;
however, no differences existed between these two gel conditions when PTH was added.
After two days in culture, ColX expression was significantly greater (p<0.05) in
chondrocytes encapsulated in the unmodified alginate gels compared to those cultured in
RGD-alginate, when no PTH was added to either gel condition. However, no difference
was observed between the Unmodified + PTH and RGD + PTH conditions on Day 2. For
both gel conditions, PTH treatment resulted in significantly reduced (p<0.05) expression
of ColX in encapsulated chondrocytes by Day 2 compared to the corresponding gel
conditions without PTH treatment. On Day 3 of culture, chondrocytes in the
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Unmodified/no PTH group still exhibited the greatest expression of ColX (p<0.05)
compared to the RGD-alginate conditions. Furthermore, expression of ColX was
significantly lower (p<0.05) in chondrocytes cultured in RGD-gels treated with PTH,
compared to those in RGD-gels without the addition of PTH. Results for the Unmodified
+ PTH treatment group were undetermined for Day 3.
Likewise, expression of Ihh (Fig. 4-4B) on Day 1 of culture was significantly
greater (p<0.05) in the RGD-alginate treatment group compared to the unmodified
alginate treatment group, when no PTH was added to either condition. PTH treatment led
to significantly lower Ihh expression in chondrocytes cultured in RGD-alginate gels,
while no difference was observed between the Unmodified/no PTH and Unmodified +
PTH groups. On Day 2 of culture, Ihh expression was significantly highest (p<0.05) in
the Unmodified/no PTH treatment group. Furthermore, PTH-treated groups of both
unmodified and RGD-alginate gels exhibited significantly lower (p<0.05) expression of
Ihh compared to the corresponding gel condition without PTH. Although expression
levels were significantly different between unmodified alginate and RGD-alginate
conditions when no PTH was added, no difference was observed between the two gel
conditions when PTH was incorporated into the culture media. On the third day of
culture, no differences in Ihh expression existed between the unmodified alginate and
RGD-alginate gel conditions, with or without the addition of PTH. However, Ihh
expression was significantly reduced (p<0.05) in both gel conditions treated with PTH
throughout the culture period.
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Fig. 4-4. Expression levels of A. collagen X (ColX), B. Indian hedgehog (Ihh), and C. Sox9
(Sox9) mRNA from chondrocytes cultured in unmodified alginate gels (Unmodified),
unmodified gels with 1 µM PTH (Unmodified + PTH), RGD-alginate gels (RGD), and RGDalginate gels with 1 µM PTH (RGD + PTH). Means ± standard deviation values are expressed
as a relative quality (RQ). RQs with different superscripts within each day for each transcript
are significantly different (P < 0.05). ColX results for the unmodified alginate/1µM PTH
condition were undetermined for Day 3.

On Day 1 and Day 2 of culture, no statistical differences in Sox9 expression (Fig.
4-4C) existed between treatment groups. On Day 3, however, Sox9 expression in
chondrocytes cultured in the RGD + PTH condition was significantly greater (p<0.05)
than those cultured in the unmodified alginate conditions, with and without the addition
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of PTH. When no PTH was added to either gel condition, no statistical differences were
observed between the unmodified alginate and RGD-alginate groups. Furthermore, PTH
addition did not significantly effect Sox9 expression on Day 3 in either the unmodified or
RGD-alginate gel conditions.

4.4. Discussion
In the present study, unmodified and RGD-conjugated alginate hydrogel gels
were used as an artificial 3-D matrix for growth plate chondrocyte culture over the course
of 3 days, with and without the exogenous addition of soluble PTH. Previous studies have
employed unmodified alginate gels for the in vitro culture of growth plate chondrocytes
to evaluate the effects of 3-D culture on the expression of differentiation markers [92], as
well as the effects of gelation conditions on chondrocyte formation in vitro [12],
demonstrating that alginate gels are able to maintain chondrocyte genotype and
phenotype in vitro compared to monolayer culture. Furthermore, RGD-conjugated
alginate gels, in particular, have previously been investigated in several studies for their
effects on chondrocyte behavior and chondrogenesis, including in vivo articular cartilage
growth [24], in vitro chondrogenesis of bone marrow stromal cells [138], and calcium
signaling response of articular chondrocytes to fluid flow [139]. However, the present
study is the first to use an in vitro alginate model to test the effects of RGD ligands and
soluble PTH on the behavior and gene expression of encapsulated growth plate
chondrocytes.
The alginate encapsulation method utilized in this study was able to maintain
chondrocyte viability throughout three days of culture, as demonstrated by live/dead
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staining of a representative bead on each day. Furthermore, cell viability appeared to be
unaffected by extra time spent in alginate solution prior to crosslinking, which can be
concluded from the live/dead staining images of the first and last beads that were
prepared from the alginate/cell suspension for the RGD/no PTH condition. These results
confirm alginate’s gentle encapsulation process and its favorable use as a 3-D artificial
matrix. No clear trends in cell proliferation could be concluded from EdU staining of the
chondrocytes, despite some small differences between groups. Although the RGD peptide
ligands did increase percent proliferation by Day 3 compared to the corresponding
unmodified alginate condition, a larger proliferative effect was expected due to the
peptide’s known ability to increase proliferation in other cell types cultured in RGDalginate gels [14, 27, 140]. These results, however, could be explained by the RGD
ligand density chosen for this study (4 µmol/g), which may have been too low to induce
substantial proliferation effects in the growth plate chondrocytes cultured in our system.
Similarly, PTH treatment did not have a substantial effect on chondrocyte proliferation,
although it did promote a slightly higher percentage of proliferating chondrocytes by
Days 2 and 3 of culture. Unlike the results for RGD effect on proliferation, these PTH
results were not surprising; the results of the present study support previous reports that
revealed that Ihh is the driving force of proliferation in the growth plate and is
independent of PTHrP signaling [141]; that is, changes in PTHrP-related parameters
interact specifically with hypertrophy, as opposed to affecting rate of proliferation [86,
142].
In growth plate cartilage in vivo, PTHrP binds to its PTH/PTHrP receptor
expressed by proliferating chondrocytes and suppresses chondrocyte hypertrophy,
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retaining the chondrocytes in the proliferative zone [83, 85]. In areas where PTHrP
concentration drops below a critical level, chondrocytes stop proliferating, begin
hypertrophy, and start to produce Ihh and type X collagen [84]. Hence, PTHrP, and
therefore PTH, acts to delay chondrocyte hypertrophy. According to the results of the
present study, our alginate system was able to mimic this occurrence in vitro by Day 2
and Day 3 of culture, which was indicated by the significantly lower expression of both
ColX and Ihh as a result of PTH addition to chondrocytes cultured in unmodified and
RGD-alginate gels. The Day 1 results, which did not follow this trend, can most likely be
explained by the chondrocytes recovering from the dissection and encapsulation process
and adjusting to the in vitro environment during this time; hence, 24 hours was not a long
enough time for real changes in maturation state to occur. The fact that proliferation rates
were not affected by PTH treatment despite greater Ihh expression in encapsulated
chondrocytes that were not treated with PTH suggests that Ihh production, enabled by a
lack of PTH, did not yet have time to stimulate chondrocyte proliferation by Day 3.
Longer culture times could be evaluated in future studies to reveal this effect.
Interestingly, RGD conjugation to alginate also suppressed the expression of
hypertrophic markers in our in vitro system by days 2 and 3 compared to unmodified
alginate gels. However, the addition of PTH to the culture media of unmodified and
RGD-conjugated alginate gels eliminated the differences in hypertrophic gene expression
that existed between the two gel conditions without the PTH treatment; therefore, PTH
treatment, at the 1 µM concentration we used, overrides the hypertrophic effect of
unmodified alginate on encapsulated chondrocytes when comparing to the same
treatment in the RGD-alginate condition. The suppression of hypertrophy by RGD
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peptide conjugation to alginate supports results from previous studies that investigated
the effect of RGD ligands on chondrogenic differentiation in vitro [143, 144]. In a
previous study involving the culture of growth plate chondrocytes seeded on fibronectin,
an ECM protein that contains the RGD peptide as its active site, exogenously added RGD
to the media resulted in increased alkaline phosphatase levels, implying terminal
differentiation [143]. The terminal differentiation could be explained by the act of the
exogenously added RGD blocking the link between cellular integrins and the RGDcontaining fibronectin protein, suggesting that interactions of chondrocytes with RGD
ligands suppress terminal differentiation [143]. This effect was also demonstrated in the
current study utilizing RGD-conjugated alginate; that is, higher ColX and Ihh expression
levels in the unmodified gel condition compared to the RGD-conjugated gel condition
indicated that hypertrophic effects were increased in the absence of RGD ligands.
Finally, Sox9 is a known transcription factor that acts at every stage of
chondrocyte differentiation in the growth plate, from the formation of condensations by
mesenchymal cells to the transformation of proliferating chondrocytes into hypertrophic
chondrocytes [83, 145]. As Sox9 is essential for chondrocyte formation, Sox9 expression
is often used as a marker for chondrocyte differentiation in in vitro studies to detect or
confirm chondrogenic lineage. In the present study, Sox9 expression levels were
evaluated to ensure that chondrocytes from each treatment group were not
dedifferentiating during culture with respect to the other treatment groups. Overall, Sox9
expression was similar in all treatment groups on each day, confirming that differences in
Ihh and ColX expression levels between groups were not a result of dedifferentiation
effects.
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In conclusion, this report reveals that PTH treatment and RGD peptide ligands
suppress hypertrophy after Day 1 in chondrocytes cultured in alginate hydrogels,
demonstrating the ability of these factors to regulate growth plate chondrocyte behavior
within our 3-D culture system. This study was the first step utilizing this alginate culture
model to evaluate factors necessary for inducing native growth plate architecture and
function in vitro. Future studies with our 3-D in vitro culture system can focus on the
effects of treatment with other signaling factors, such as Ihh, and the combination of
signaling factors to produce feedback loops as seen in vivo. Furthermore, dose-dependent
effects of PTH and other factors, along with variations in RGD ligand density and gel
mechanics, can be investigated with our alginate culture system to identify optimal
conditions for in vitro chondrocyte culture. Knowledge of the effects of these factors can
be used to establish zonal arrangement of growth plate chondrocytes in vitro through the
use of signaling gradients, which would have a significant impact on tissue engineering
strategies for the replacement of growth plate cartilage damaged due to injury or disease.
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CHAPTER 5
Future studies and conclusions
5.1. Introduction
In this thesis, alginate hydrogel was first designed and characterized for its use as
a 3-D matrix for in vitro models of tissue development. After demonstrating its ability to
be manipulated in shape, chemical structure, and mechanical properties, alginate gels
were employed as an artificial extracellular matrix (ECM) for pre-implantation pig
embryo culture in vitro. This study validated the potential of the alginate culture system
to serve as a matrix for an in vitro model of pig embryo development, in particular
elongation during the pre-implantation stage of pregnancy. Next, unmodified and
GRGDSP-conjugated alginate gels were used for the encapsulation and culture of mouse
growth plate chondrocytes. This culture system was used as a model to study the effects
of parathyroid hormone (PTH) and GRGDSP peptide conjugation on chondrocyte
behavior, demonstrating that both PTH and RGD adhesion ligands decrease expression of
collagen X and Indian hedgehog (Ihh) transcripts, two markers for hypertrophic
chondrocytes, relative to control treatments. Together, the results presented in this thesis
indicate alginate’s promising use as a 3-D matrix for in vitro models of pig embryo
development as well as growth plate development. Future studies are needed to further
investigate factors and mechanisms involved in development of these tissues, utilizing
our alginate hydrogel system as the in vitro research tool. Recommended studies for both
projects are described in detail below.
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5.2. Future directions for the in vitro pig embryo model
In Chapter 3, an in vitro culture system was established using a 3-D alginate
hydrogel matrix that can support native embryo architecture and facilitate morphological
changes of porcine embryos at the onset of elongation, in base serum media without the
addition of special growth factors [50]. Furthermore, this system was shown to induce a
corresponding increase in estrogen production and steroidogenic transcript expression,
consistent with in vivo elongation [50]. With a base system established, the in vitro
alginate culture system can now be used as a model for evaluating the effect of specific
and undefined uterine factors on pre-implantation embryo development. Therefore, future
studies involving the alginate culture model for pig embryo elongation should investigate
the molecular and cellular aspects of pre-implantation embryo development in response
to components added to the culture media or alginate gel that are known to exist in the
uterus during elongation. The following three-tiered approach is recommended: 1)
evaluate the effect of culturing encapsulated embryos within uterine flushes collected
between days 9 through 12 of gestation; 2) evaluate the effect of specific uterine factors
added to basal media or incorporated within the alginate on the development of
encapsulated embryos; and 3) investigate the effect of co-culturing the encapsulated
embryos with uterine lumen and glandular epithelial cells. Each of these approaches is
described in detail below.
The uterine environment prepares for embryo elongation and implantation by
releasing nutrients, metabolites, and hormones in a time-dependent manner relative to
paracrine signals from the embryo (i.e., estrogen) and endocrine/paracrine signals within
the endometrium (i.e., progesterone) [69, 70, 146]. It has been shown that total protein
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increases in the uterine lumen from day 7 to 10 in both cyclic and pregnant gilts followed
by a more significant increase from day 10 to 13 [147]. Therefore, an evaluation of
uterine milieu between days 9 through 12 of gestation should be made by adding uterine
flushes from these pregnancies to basal culture media to determine the effect of
undefined uterine components on embryo development within our alginate culture
system. Preliminary studies were conducted to investigate whether uterine flushes from
day 9 or day 10 of gestation were capable of supporting in vitro embryo development of
in vivo-derived day 9 porcine embryos using the 3-D alginate culture system. Embryos
collected on day 9 of gestation were assigned to be cultured in pooled day 9 flushes, day
10 flushes, or base serum media for 96 hours within 0.7% alginate gels. Our
morphological results revealed that encapsulated embryos cultured in base serum media
(as used for the system in Chapter 3) exhibited the greatest percentage of morphological
changes (22.22%) compared to the encapsulated embryos cultured in the day 9 (12.5%)
or day 10 flushes (16.67%), as shown in Table 5-1. Furthermore, the trend was similar
when comparing the percentage of surviving embryos with morphological changes across
the media treatment groups (Table 5-1).
In addition to observing embryonic survival and morphological changes, real-time
PCR was used to analyze steroidogenic transcript expression at 96 h in the encapsulated
embryos cultured in the uterine flushes compared to those cultured in base serum media.
Overall, expression of steroidogenic transcripts STAR, CYP11A1 and CYP19A1 was
greater in encapsulated embryos cultured in base serum media (Enc serum) compared to
embryos cultured in the pooled day 9 (Enc d9) or day 10 flushes (Enc d10) (Fig. 5-1).
Expression of STAR, CYP11A1 and CYP19A1 are known to be increased in a similar
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pattern as estrogen production during embryo elongation [130, 131]; therefore, greater
expression of these transcripts in the Enc serum group correlates with the higher
percentage of morphological changes that occurred compared to the Enc d9 and Enc d10
groups.
Table 5-1. Summary of embryo survival and morphological changes observed following
96 h culture of day 9 porcine embryos encapsulated in 0.7% alginate gels. Encapsulated
embryos were assigned to be cultured in day 9 uterine flushes (D 9), day 10 uterine flushes
(D 10), or in base serum media (Serum).
Treatment

D9

D 9 Cont

D 10

D 10 Cont

Serum

Serum Cont

Total no. of embryos

24

6

24

6

18

10

Embryo survival (n)

8

4

10

4

7

5

Embryo survival (%)

33.33%

66.67%

41.67%

66.67%

38.89%

50.00%

Morph change (n)

3

0

4

0

4

0

12.50%

0.00%

16.67%

0.00%

22.22%

0.00%

37.50%

0.00%

40.00%

0.00%

57.14%

0.00%

Morph change from all
embryos (%)
Morph change from
surviving embryos (%)

Fig. 5-1. Expression levels of CYP11A1 (blue), CYP19A1 (red), and STAR (green)
mRNA measured by qPCR from Enc d 9 (encapsulated embryos cultured in d9
flushes), Enc d 10 (encapsulated embryos cultured in d10 flushes) and Enc serum
(encapsulated embryos cultured in serum media). Data were log-transformed
before analysis and back-transformed to observable values. Least-squares means
± SEM values are expressed as a relative quality (RQ).
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These preliminary results indicate that soluble factors present in uterine flushes at
day 9 or day 10 of gestation do not support in vitro embryo development for 96 hours
within our 3-D alginate culture system as efficiently as base serum media. These results
are likely due to asynchrony issues between the embryos and their corresponding
environment, which has previously been suggested to be one of the causes of early
embryonic loss during the elongation stage of embryo development [148]. For example,
an early increase in estrogen in the uterine environment of pregnant pigs (demonstrated
by in utero injections 20-30 hours prior to elongation) stimulated a pre-mature increase of
uterine secretions, resulting in increased embryo loss that was most likely due to the
asynchrony of the embryos with the uterine environment [148]. Therefore, to overcome
this issue, future studies with uterine flushes should involve a sequential uterine flush
media system (i.e. sequential culture in day 9 through day 12 uterine flushes) to achieve
appropriate synchrony between the embryo and the corresponding environment, thus
establishing the most effective system to mimic in vivo elongation. Mass spectrometry
can then be used to determine the specific proteins and growth factors within the pools of
uterine flushes to determine differential concentrations of each factor in the flushes from
days 9 through 12 of gestation, in order to correlate these factors to embryo development.
In addition to undefined factors in uterine flushes, specific components upregulated within the uterine milieu during early pregnancy (e.g., TGFBs, FGF7, and
OPN) should also be evaluated to explore biological pathways regulated during the preimplantation stage of embryo development. Adding these components to a basal media or
within the alginate gels can be used to identify specific regulatory pathways that drive
embryo elongation prior to implantation. Osteopontin (OPN), in particular, is an ECM
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glycoprotein secreted by uterine epithelial cells that plays a role in the porcine
implantation cascade during pregnancy [71]. OPN production by uterine epithelial cells is
induced by estrogens secreted by the embryo during elongation and has been reported to
stimulate cell-cell adhesion, increase cell-ECM interactions, and promote cell migration
[149, 150]. Previous evidence suggests that the arginine-glycine-aspartic acid (RGD)
peptide of OPN binds to integrin ανβ6 on the embryonic trophectoderm, inducing
cytoplasmic reorganization during embryo elongation by stimulating cell-cell adhesion
and promoting cell migration [151]. In previous in vitro studies, OPN has been shown to
enhance development of early porcine embryos to the blastocyst stage when added
exogenously to culture media [72]. Furthermore, Erikson and colleagues demonstrated
that OPN stimulates migration of porcine trophectoderm cells via haptotaxis, supporting
the hypothesis that OPN mediates cell migration during elongation [151]. Their results
also indicated that the RGD sequence of OPN is required to stimulate haptotaxis of the
trophectoderm cells, as no migration was observed with the OPN that contained a
mutated binding sequence [151]. Given the potential involvement of OPN and other
uterine factors during early embryonic development in the pig, further investigations are
warranted to elicit the exact mechanisms by which these factors regulate pig embryo
elongation. The alginate hydrogel system described in Chapter 3 was able to facilitate
embryonic growth without any adhesion between the embryo and the matrix; this in vitro
system can now serve as a “blank slate” for evaluating these mechanisms by
incorporating factors that promote cellular adhesion and migration.
Preliminary studies have been performed to evaluate the effect of OPN and, more
specifically, an RGD peptide sequence on embryo elongation within the in vitro alginate
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hydrogel system. Day 9 pig embryos were encapsulated in one of the following treatment
groups, using the same method as described in Chapter 3: unmodified alginate gels (Alg),
alginate gels incorporating 0.1 µg/mL OPN (Alg + OPN), or alginate gels conjugated
with GRGDSP peptide (RGD-Alg; prepared as described in Chapter 2). Nonencapsulated embryos were used as a control group (Control). Results from these studies
indicated that RGD-Alg promoted the greatest percentage of embryo survival (~68%)
compared to the Alg and Alg + OPN treatment groups (Table 5-2). Furthermore, RGDAlg induced the greatest percentage of embryo morphological changes from all embryos
(~43%) and from surviving embryos (~63%). The Alg + OPN treatment promoted
intermediate percentages of embryo morphological changes from all embryos (~31%)
and from surviving embryos (~62%). Representative images of embryos from each
treatment group are pictured in Fig. 5-2. These results suggest the necessary role of OPN,
and more specifically its RGD peptide, for proper embryo elongation. Additional studies
are warranted for investigating a dose-effect of OPN and various RGD ligand densities
on embryo development, along with the evaluation of triggered signaling pathways, to
determine optimal levels for embryo elongation and mechanisms by which elongation is
promoted by these factors.
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Table 5-2. Summary of embryo survival and morphological changes observed
following 96 h culture of day 9 porcine embryos encapsulated in unmodified
alginate (Alg), alginate blended with 1 µg/mL osteopontin (OPN), alginate
conjugated with GRGDSP, and non-encapsulated control embryos (Control).
Treatment

Alg

Alg + OPN

RGD-Alg

Control

Total no. of embryos

16

16

16

16

Embryo survival (n)

8

8

11

6

Embryo survival (%)

50.00%

50.00%

68.75%

37.50%

Morph change (n)

3

5

7

0

18.75%

31.25%

43.75%

0.00%

37.50%

62.50%

63.64%

0.00%

Morph change from all
embryos (%)
Morph change from
surviving embryos (%)

Control

Alg

RGD-Alg

Alg + OPN

0 hr

96 hr

Fig. 5-2. Representative images of Alg, RGD-Alg, and Alg + OPN embryos that
changed morphologically by 96 hours of culture, along with a control embryo
that did not change morphologically, other than swelling.

Many of the factors within the uterine milieu that are described above are secreted
by maternal epithelial cells via embryo-maternal signaling [68]. Because embryomaternal communication is vital for proper embryo development during the preimplantation stage of pregnancy, future studies should involve the co-culture of uterine
lumen and glandular epithelial cells with the encapsulated embryos to determine if this
embryo-maternal cross-talk can be mimicked in our alginate hydrogel system. The co-
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culture model could lead to better understanding of specific embryo-uterine interactions
during the elongation process. For co-culture studies, reproductive tracts can be collected
from pregnant gilts to isolate uterine epithelial cells. Luminal and glandular epithelial
cells can then be isolated and prepared for culture following a previously reported
procedure [152]. After establishing a monolayer of these cells in culture, two different
approaches are recommended for co-culturing the uterine cells with encapsulated preimplantation pig embryos. First, the uterine cells can be mixed in with the alginate prior
to encapsulation, resulting in a cell-embedded gel surrounding the embryo (Fig. 5-3A).
With this approach, the uterine epithelial cells would be surrounding the embryo in all
directions, allowing for a more direct exposure to secretory factors. The second
recommended approach involves culturing the alginate-encapsulated embryo on a
monolayer of uterine epithelial cells (Fig. 5-3B). This approach would better mimic the
uterine lumen environment, but would prevent direct contact between the embryo and
uterine cells. Therefore, future studies employing both of these approaches would be
attractive for establishing and evaluating maternal-embryo crosstalk in our in vitro
alginate culture system. Overall, studies involving undefined uterine flushes, defined
uterine components, and co-culture studies can be used together to identify and explore
biological pathways regulated during the pre-implantation stage of pig embryo
development.
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A
Embryo

Uterine
epithelial cells

B
Embryo

Uterine
epithelial cell
monolayer

Fig. 5-3. Schematic illustration of the approaches for co-culturing uterine cells with
encapsulated pig embryos. A) Uterine epithelial cells can be mixed in with the alginate
solution prior to encapsulation, resulting in the cells surrounding the embryo in all directions.
B) Encapsulated embryo can be cultured on a monolayer of uterine epithelial cells.

Once uterine factors are evaluated and optimized to promote proper embryo
elongation in vitro, the alginate culture system can be used to investigate biomechanical
effects on elongation by culturing cells in various concentrations of alginate hydrogels,
i.e. gels varying in stiffness (as demonstrated by mechanical testing in Chapter 2).
Previous studies have found evidence that stiffness is important during embryogenesis in
vivo. For example, during gastrulation in xenopus laevis, stiffening of the involuting
marginal zone occurs to prevent the embryonic tissue from collapsing [153]. However, it
remains unclear whether these changes in tissue stiffness occur solely for the purpose of
providing mechanical stability or also occur in order to regulate other cellular processes
via mechanotransduction [96]. Due to the complicated task of evaluating mechanical
forces in vivo, an in vitro embryo model is necessary for understanding complex
developmental behaviors that are regulated by mechanical forces. Preliminary studies
involving the culture of day 9 pig embryos in 0.375%, 0.7%, and 1.5% alginate gels in
base serum media demonstrated that 0.7% alginate promoted the greatest extent of
embryonic morphological changes (data not shown); however, because mechanical
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properties may play a role in biochemical signaling, future studies should revisit the
investigation of alginate biomechanics on embryo development in conjunction with
optimal uterine factors and/or co-cultures. Furthermore, future studies with this model
could investigate the effect of a mechanical gradient on embryo elongation, in which
outer gel layers are composed of increasing concentrations of alginate. This approach
would allow for the embryo to reside in a more permissive environment until it elongates
and reaches the stiffer outer layers, which may help to prevent the embryo from extruding
from the gel. The cylindrical and tubular alginate gels as well as the alginate wells
described in Chapter 2 could also be used to investigate the effect of alginate
biomechanics on embryo development; these methods would provide a greater amount of
space for the embryo to elongate compared to the bead method, which resulted in
embryos growing out of the gel by the end of culture in the studies described in Chapter
3. Utilizing each of the aforementioned methods to investigate the influence of matrix
biomechanics on pig embryo elongation could lead to the understanding of mechanical
stability that may be required for proper elongation to occur.
In addition to using our alginate system for studying molecular, cellular, and
mechanical factors that promote elongation, as described above, future studies should
encompass a more extended evaluation of embryo development in order to better
correlate the in vitro results to in vivo occurrences. Unlike elongation in other domestic
animals, rapid elongation of the pig embryo has been primarily associated with cellular
remodeling and differentiation rather than cellular hyperplasia [61]. As a result, potential
markers for differentiation of the trophectoderm (i.e., cytokeratin-18 [KRT18]) and
mesoderm (i.e., vimentin [VIM]) have been identified in the elongating pig blastocyst
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[62-64]. Therefore, future studies should assess cellular differentiation and proliferation
in embryos that undergo a morphological change within the alginate hydrogels to
determine if the growth is occurring via differentiation. One recommended method is to
measure the expression of KRT18 and VIM transcripts in the encapsulated embryos and
compare the expression levels to those of in vivo control embryos. Another recommended
method involves a measure for the proliferation status of a cell population. Cellular
proliferation can be quantified by determining mitotic index, i.e. the ratio of cells
undergoing mitosis (condensed DNA) to the total number of visible cells. To calculate
this ratio, nuclei in the embryos can be stained with DAPI and imaged with confocal
microscopy. Cells in which the chromosomes are visible instead of an intact nucleus can
be counted as undergoing mitosis. Preliminary staining of nuclei and actin on a day 9 in
vivo-derived embryo was performed as a test, and representative confocal images are
shown in Fig. 5-4 (white arrows indicate cells undergoing mitosis). Future investigations
of mitotic index of embryos cultured in the alginate hydrogel system will determine if our
encapsulated embryos change morphologically via similar mechanisms as in vivo
elongating embryos, which will aid in demonstrating alginate’s ability to serve as a 3-D
matrix for a developmental model of embryo elongation.
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A

B

Fig. 5-4. Confocal microscopy images of in vivo-derived Day 9 embryo with actin and
nuclei stained with phalloidin and DAPI, respectively. A) 10x magnification, scale bar =
500 µm; B) 60x magnification, scale bar = 50 µm. Mitotic figures are denoted with white
arrows in the 60x magnification image.

5.3. Future directions for the in vitro growth plate model
In Chapter 4, 3-D alginate hydrogels were used as an in vitro extracellular matrix
for growth plate chondrocytes to investigate the effect of RGD peptide ligands as well as
exogenously added parathyroid hormone (PTH) on chondrocyte behavior in vitro. With
this alginate culture system, we were able to determine that alginate conjugated with an
RGD peptide suppressed chondrocyte hypertrophy compared to unmodified alginate,
demonstrating the effect of this extracellular matrix adhesion peptide on chondrocyte
behavior in vitro. Furthermore, the addition of PTH to the culture media of both RGDalginate and unmodified alginate cultures also repressed hypertrophy, as concluded by the
lower expression of collagen X and Ihh transcripts in cells cultured with PTH compared
to those cultured without PTH; these results demonstrated that the effect of PTH on
chondrocyte hypertrophy in the growth plate can be mimicked to an extent within our in
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vitro alginate culture system. This study was the first step in using the alginate culture
model to evaluate factors necessary for inducing native growth plate architecture and
function for potential tissue engineering applications. The recommended next step is to
evaluate PTH effect in a dose-dependent manner by varying PTH concentration. Future
studies are then warranted for the investigation of signaling feedback loops, signaling
gradients, mechanical gradients, and co-culture studies on in vitro chondrocyte behavior,
utilizing alginate as the 3-D culture matrix. Recommended studies are described in detail
below.
Together, the interactions of parathyroid hormone-related protein (PTHrP) and
Indian hedgehog (Ihh), a member of the hedgehog family of secreted ligands, form a
feedback loop that regulates the length of the proliferative columns in growth plate
cartilage and defines individual zones of chondrocyte maturation [83-85]. Studying
factors independently and observing their isolated effects can lead to greater insight into
the performance of a system as a whole. Therefore, in addition to observing PTH effects
on chondrocyte behavior in vitro as described in Chapter 4, it is recommended that Indian
hedgehog (Ihh) also be investigated independently for its effects on the in vitro behavior
of growth plate chondrocytes. Sonic hedgehog (Shh) binds to the same receptors as Ihh,
leading to activation of the same signaling pathways; hence, Shh can be used to represent
the effects of Ihh. A preliminary study was conducted to observe the effects of 0.2 ng/mL
and 0.5 ng/mL Shh on neonatal mouse growth plate chondrocytes encapsulated within
GRGDSP-conjugated alginate gels. RT-PCR was performed to determine gene
expression of transcripts involved in growth plate development and function. Expression
levels of collagen X (Fig. 5-5A) and PTHrP (Fig. 5-5B) are reported here as an example
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of transcript expression results obtained from this study. A dose-dependent effect of Shh
was difficult to determine from the gene expression results of this preliminary study,
suggesting that the concentrations of Shh used (0.2 ng/mL and 0.5 ng/mL) were too low
for our model. Due to hindered diffusion to the cells through the alginate gel,
recommended concentrations for future Shh experiments should be an order of magnitude
higher to observe clear effects.

A

B

Fig. 5-5. Expression levels of A. Collagen X and B. PTHrP measured by RT-PCR from
chondrocytes encapsulated in RGD-alginate and cultured with, 0 ng/mL, 0.2 ng/mL, or 0.5
ng/mLsonic hedgehog (Shh). Means ± SEM values are expressed as a relative quantity (RQ).

Once PTH and Shh are evaluated independently in the alginate model, their
cooperative effects should then be evaluated by delivering both PTH and Shh to alginateencapsulated growth plate chondrocytes during the same experiment. Dose-dependent
effects should be tested again for these cooperative studies as the optimal concentrations
of each factor may change when added to culture media together.
Another variable that should be tested in future studies is the incorporation of
PTH and/or Shh into the alginate solution prior to crosslinking, in contrast to adding the
factors to the culture media after beads are crosslinked, as was done in the study
described above and in Chapter 4. This approach would be advantageous for maintaining
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an efficient localized concentration of signaling factors around the cellular environment
throughout the duration of culture. Preliminary release studies demonstrated alginate’s
ability to retain PTH within the beads for a duration of 5 days, with very little release
during this time (data not shown). If longer release studies show that a more sustained
release is needed for longer culture times, recommended studies should investigate the
incorporation of heparin into the alginate beads; the heparin should bind to the signaling
factors and aid in preventing release. Another option to promote sustained release (and
therefore inhibit burst release) from alginate hydrogels would be to chemically modify
alginate with sulfate groups. Sulfation of alginate mimics heparin’s affinity for certain
growth factors, including PTH and Ihh/Shh, and has previously been used to provide
protection and sustained release of heparin-binding growth factors [42]. However,
published methods for sulfation of alginate involve the use of harsh solvents, specifically
the reaction of alginate with chlorosulfuric acid in formamide [39]. Future studies
involving the investigation of signaling factors within the alginate model should explore
the possibility of a safer, non-toxic method to achieve alginate sulfation. In vivo, Ihh
diffusion from hypertrophic cells to perichondral cells is regulated by Ihh binding to
heparan sulfate in the extracellular matrix [86]. Therefore, the incorporation of heparin or
conjugation of sulfate groups would allow the alginate system to better mimic the in vivo
extracellular matrix of the growth plate.
In addition to investigating the effects of soluble factors added to our chondrocyte
culture system, RGD ligand density should be varied and studied for its effect on
chondrocyte behavior. The methods described in Chapter 4 involved the conjugation of
GRGDSP peptide to alginate at only one concentration, and this particular concentration
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(estimated to be approximately 4 µmol/g alginate [14]) significantly decreased the
expression of collagen X in encapsulated chondrocytes compared to unmodified alginate,
suggesting a decrease in the amount of hypertrophic cells. Varying the concentration of
GRGDSP on the alginate backbone will vary the amount of cellular adhesion sites, and
may therefore further affect proliferation and/or hypertrophy of encapsulated
chondrocytes [27]. Peptide conjugation, however, occurs on the carboxylic acid groups of
the alginate polymer backbone, which are the same groups that participate in ionic
crosslinking with calcium for hydrogel formation [39]. As a result, increasing ligand
density may decrease the stiffness of resulting gels. Young’s moduli of gels with various
RGD peptide densities should therefore be tested to determine if mechanics differ
significantly with increased ligand density.
Finally, mechanical and chemical gradients should be established with these
alginate hydrogels and investigated for their effects on in vitro growth plate chondrocyte
behavior. The cylindrical gel method (Fig. 5-6A and 5-6B) or layered bead method (Fig.
5-6C and 5-6D), both described in Chapter 2, can be used to establish these gradients.
With the cylindrical gel method, chondrocytes can be encapsulated within the middle
area of the cylinder to represent the proliferative zone. Ihh can then be incorporated at a
high concentration at one end of the cylinder, representing the hypertrophic zone of Ihhexpressing chondrocytes, with decreasing concentrations towards the other end of the
cylinder. At the opposite end, PTH can be incorporated at high concentrations,
representing the resting zone, with decreasing concentrations towards the Ihhconcentrated end. This method is depicted in Fig. 5-6A. A co-culture study involving
transfected HEK293T cells that express Ihh or PTH could also be used to establish
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signaling gradients in place of the factors themselves (Fig. 5-6B). The layered bead
method uses a similar approach in that chondrocytes can be encapsulated in a middle
layer, with PTH and Ihh or PTH- and Ihh-expressing cells incorporated into the inner and
outer gel layers (Fig. 5-6C and 5-6D). Preliminary studies involving the encapsulation of
rat chondrosarcoma (RCS) cells with Ihh-expressing HEK293T cells within alginate
beads demonstrated that RCS cells were successfully encapsulated within an outer gel
layer surrounding an inner bead of HEK293T cells (Fig. 5-7).

A.#

B.#

Chondrocytes

Chondrocytes
Ihh

PTH

Cells expressing
PTH
Ihh

C.#

D.#

Cells expressing
Ihh

Cells
expressing
Ihh

Cells
expressing
PTH

PTH

Chondrocytes

Chondrocytes

Fig. 5-6. Schematic illustration of the encapsulation of chondrocytes and formation of
chemical gradients within alginate hydrogels via incorporated signaling factors (A,C) or
co-culture with factor-expressing cells (B,D). Gradients can be established in a cylindrical
gel formation (A,B) or with a layered bead method (C,D).
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RCS

HEK

Fig. 5.7. 1.5% RGD-alginate bead with two gel layers, consisting of Ihhexpressing HEK293T cells (HEK) encapsulated within the inner bead and
rat chondrosarcoma cells (RCS) encapsulated within the outer layer. Cells
were live/dead stained prior to imaging with a fluorescence microscope.

For both the cylindrical gel method and layered bead method, different
concentrations of alginate can be used in each layer to establish a gradient of mechanical
properties to determine biomechanical effects on growth plate chondrocyte behavior. A
recent approach to the manipulation of transcription factors that have been discovered to
play important roles in cartilage and bone formation is to consider the mechanical
influences on their regulation [84]. For example, studies have revealed that
biomechanical stimuli influence the regulation of NF-κβ transcription factors, which
generate intracellular signals that induce or suppress pro-inflammatory and reparative
genes in chondrocytes [154, 155]. Furthermore, a study involving chitosan substrates of
varying stiffness properties revealed that increased stiffness promoted articular
chondrocyte growth and proliferation [156], linking the biomechanical environment to
cartilage development and function. Therefore, future studies involving mechanical
gradients within our in vitro growth plate model could reveal biomechanical mechanisms
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that underlie spatial organization of chondrocytes in the growth plate. Taken together, the
optimal combination of appropriate biomechanics, ECM factors, and signaling gradients
are hypothesized to generate native cartilage architecture in vitro, in particular a distinct
zone of proliferating columnar chondrocytes as seen in vivo.

5.4. Conclusions
This thesis describes the establishment of in vitro culture systems for preimplantation pig embryos and growth plate chondrocytes via a tissue engineering
approach, utilizing alginate hydrogels as a 3-D scaffold. Alginate, a linear polysaccharide
derived from brown algae, demonstrated tunable physical and chemical properties,
making it an ideal matrix for in vitro culture models. In regards to pig embryo culture,
embryos encapsulated within alginate hydrogels exhibited greater survival and
morphological change than non-encapsulated control embryos, along with increased
expression of steroidogenic transcripts and estrogen production, consistent with in vivoelongation. However, this system consisted of only a base serum media; therefore, future
studies should use this alginate hydrogel system as a tool for evaluating specific uterine
and/or biomechanical factors that play a role in embryo elongation, with further endpoint
evaluations to characterize elongation. These factors can then be targeted to improve
pregnancy outcomes, thereby increasing sow productivity and the profitability of swine
production. In addition, alginate hydrogels were used for the encapsulation of growth
plate chondrocytes in vitro to study the effects of soluble PTH, a signaling factor that
regulates growth plate structure and function, along with the effects of an RGD peptide
conjugated to alginate. This study demonstrated that both PTH and RGD peptide ligands
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play a role in the regulation of chondrocyte hypertrophy in our in vitro alginate system
with similar effects as seen in vivo, as indicated by the decrease in collagen X and Ihh
transcript expression. However, this study was only the first step in the evaluation of
factors that effect growth plate chondrocyte behavior to determine necessary factors for
inducing native growth plate architecture in vitro. Future studies using this alginate
system should involve the investigation of dose-dependent effects of signaling factors
and RGD peptide ligands, as well as mechanical and/or chemical gradients on
chondrocyte structure and function. Knowledge of microenvironmental parameters that
induce cartilage architecture can then be used in tissue engineering strategies to
regenerate native cartilage to address critical health issues associated with growth plate
injury and disease. Overall, information gained from utilizing these in vitro models as
research tools can be used to advance the field of developmental biology and enhance
tissue engineering therapies for the treatment of degenerative diseases.
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